rfhg_176132.1

Basic information about the TSS

---

TSS ID: rfhg_176132.1 Species: human Chr: chr15		Start: 72204979 End: 72205015 Strand: -
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000564440.5:420 BC035487:420 GeneID: 5315 HGNC/MGI_ID: HGNC:9021 UniProt_ID: Nearer transcript ids and distances:

Gene_name: pyruvate kinase M1/2 Gene_symbol: PKM Gene_synonyms: OIP3 PK3 THBP1 Gene_source: HGNC:9021

TATA-Box annotation

---

Distance to TSS:	-7210
Nearest PromoterID:	NM_001012642
Entrez ID:	196996
Nearest Unigene:	Hs.596332
Nearest Refseq:	NM_001012642
Nearest Ensembl:	ENSG00000175318
Gene Name:	pyruvate kinase M1/2
Gene Alias:	GRAMD2
Gene Type:	protein-coding
CpG%:	0.027778
GC%:	0.459459
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PKM p2@PKM p3@PKM p4@PKM p5@PKM p6@PKM p8@PKM p9@PKM p10@PKM
Sample		p1@PKM	p2@PKM	p3@PKM	p4@PKM	p5@PKM	p6@PKM	p8@PKM	p9@PKM	p10@PKM
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1259.79	8.38	6.23	3.51	3.31	1.36	0.97	0.78	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1354.52	6.07	4.05	1.82	1.42	1.62	0.00	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	1387.56	7.72	4.63	3.86	2.31	1.93	0.77	0.96	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1497.78	4.57	2.91	2.08	2.49	1.04	0.83	0.62	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1441.58	5.17	4.05	2.47	2.47	1.57	0.67	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1383.61	6.01	4.07	2.52	1.94	1.55	1.74	0.78	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1600.14	7.84	3.92	4.58	3.70	1.31	1.09	0.44	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1559.41	6.54	5.33	2.18	3.88	3.39	1.45	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1662.72	3.85	3.63	1.71	1.07	1.50	1.50	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1534.85	4.64	4.06	4.64	1.74	0.58	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1494.05	4.04	4.04	2.43	1.21	0.40	0.81	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1364.39	3.66	3.25	1.63	2.44	0.41	1.22	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1553.09	6.29	8.06	2.74	4.03	1.77	2.90	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1367.58	6.01	6.01	6.16	4.96	3.01	1.95	1.05	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	1413.04	6.59	5.49	3.07	1.98	1.98	1.54	1.54	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	1420.17	8.05	8.55	8.05	5.53	4.02	3.77	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1410.47	4.37	4.59	3.49	3.71	1.53	0.87	1.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	1364.16	3.80	7.17	5.06	7.17	2.11	4.22	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1509.89	3.20	9.06	5.86	3.73	6.40	3.20	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1432.65	5.72	3.91	3.31	2.56	1.35	2.41	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1426.73	6.82	5.21	5.21	6.15	3.88	2.81	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1253.94	5.87	5.18	2.59	2.24	0.86	2.07	1.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1329.54	5.95	5.17	3.75	4.27	2.46	3.10	1.55	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1360.88	5.58	5.82	6.07	8.98	1.94	3.40	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1399.34	3.10	5.68	5.42	3.10	2.32	2.06	0.77	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1258.45	2.22	4.43	4.75	5.06	1.27	1.27	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	1513.76	5.49	6.04	2.75	4.95	1.65	2.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1429.37	7.54	5.66	3.30	2.36	2.59	3.30	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1228.87	3.55	4.36	2.75	3.23	1.78	2.26	0.81	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	1522.46	6.33	6.33	5.25	4.52	2.71	1.99	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1504.76	3.77	6.07	3.35	3.77	2.51	1.67	1.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1537.85	4.88	3.32	2.93	3.32	1.76	2.34	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	1281.58	4.43	5.28	5.06	3.80	2.32	2.11	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1382.36	8.91	4.29	5.28	2.64	3.46	2.47	1.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1473.85	6.73	4.30	3.37	4.67	1.31	2.43	1.12	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1413.60	6.32	5.75	4.79	4.41	3.26	3.64	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1365.26	3.88	5.72	3.68	2.86	3.27	2.45	0.82	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1426.33	5.64	5.24	5.44	4.43	2.42	1.21	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1454.23	5.67	8.37	3.78	4.86	1.08	2.43	0.54	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1452.61	5.52	4.80	2.64	2.16	0.96	0.96	1.44	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1358.86	5.18	6.35	5.65	5.65	1.41	2.59	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1375.23	5.56	4.68	5.12	4.68	1.32	1.46	0.59	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	1568.63	5.69	4.01	2.95	4.64	1.90	2.11	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1538.48	4.02	3.85	3.67	5.07	2.62	3.32	0.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1655.57	3.81	4.62	3.61	2.81	1.00	2.41	0.60	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1610.61	6.05	5.35	8.14	8.38	2.79	2.33	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	1623.21	2.16	5.52	4.32	4.80	0.48	1.68	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1561.19	4.47	5.96	2.98	3.87	1.49	2.68	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1785.49	4.31	3.59	2.15	3.59	2.15	2.15	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1793.29	2.22	3.84	1.62	2.22	0.81	2.22	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1622.21	8.61	6.76	3.07	5.12	2.66	1.23	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	2237.75	8.01	4.67	4.67	7.12	3.34	2.45	1.78	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	3554.01	97.95	13.99	139.92	13.99	69.96	13.99	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	1914.81	5.68	6.03	6.03	4.97	2.48	2.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	1626.10	4.64	5.96	3.98	5.30	1.99	0.99	1.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	681.22	31.88	9.23	10.07	5.03	10.07	3.36	3.36	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1022.27	10.10	5.51	4.13	3.21	2.30	1.38	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	1807.23	8.43	11.02	7.13	6.16	4.21	2.92	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1831.31	4.18	3.85	4.50	6.74	0.64	1.61	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	993.60	10.37	7.23	4.40	3.77	3.46	1.26	1.89	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	1976.97	6.35	8.46	4.94	5.64	2.82	2.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1740.12	3.93	5.61	5.61	2.24	4.49	2.24	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	435.49	11.94	10.35	3.98	2.39	3.98	7.17	3.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1172.20	4.42	5.44	4.08	3.74	1.36	1.70	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1991.44	4.22	4.87	5.85	5.20	3.25	1.95	1.62	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1408.20	3.19	7.81	7.45	5.32	3.55	2.48	4.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2521.57	80.82	16.16	96.98	0.00	16.16	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	2337.65	102.67	23.69	47.38	15.79	7.90	0.00	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	1905.70	4.39	10.24	4.88	4.88	6.83	3.41	1.95	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	1801.01	3.47	10.41	6.94	9.42	3.97	4.96	2.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	1359.02	3.28	3.28	2.81	3.75	1.41	2.81	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1674.82	6.95	7.95	4.64	4.97	1.99	1.32	1.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	2062.07	9.28	11.14	7.11	8.04	4.33	4.64	2.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	2081.20	6.42	8.56	5.81	3.67	3.36	4.28	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	975.96	2.38	2.38	2.38	3.96	0.95	1.58	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	1068.92	10.11	4.97	3.53	4.01	2.73	0.96	2.89	1.60
Adipocyte - omental, donor1	11473-119C6	944.03	2.42	1.40	2.16	1.65	0.64	0.25	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	955.30	3.74	0.75	3.74	0.00	1.49	0.75	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	741.85	2.01	1.00	3.35	2.34	2.01	0.67	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	1330.21	4.47	4.47	7.66	1.28	3.19	0.64	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	520.07	2.20	3.30	1.10	1.10	0.00	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1234.74	2.71	4.52	1.81	5.42	1.81	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	204.71	0.35	1.39	0.52	0.35	0.52	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	657.90	1.37	3.13	1.56	1.56	0.78	0.59	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	1091.03	1.03	2.57	1.03	1.29	1.03	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	2143.48	2.79	3.62	6.41	3.90	1.95	1.39	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	795.90	0.59	0.00	0.00	1.18	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	610.25	0.88	1.21	1.53	0.97	0.80	0.40	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	1057.67	2.26	1.29	1.61	1.29	1.61	0.97	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	552.92	0.53	2.67	2.13	3.20	2.13	0.00	2.13	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	912.00	0.00	1.11	0.00	2.23	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	829.29	0.83	0.00	1.25	1.66	1.66	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	962.21	2.01	2.76	1.00	1.26	1.76	1.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	708.81	0.98	1.64	2.62	1.64	0.33	0.65	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	679.28	0.91	1.52	0.61	0.30	0.30	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	2603.57	3.98	2.43	4.42	0.88	1.77	1.77	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2932.12	8.61	5.74	3.94	2.87	4.30	3.23	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	2065.38	3.59	2.40	1.20	1.20	4.79	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	1835.22	3.78	1.80	0.72	0.90	0.72	1.62	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	2096.89	6.69	3.35	5.02	1.67	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	1789.24	6.57	4.11	3.29	2.26	1.44	1.23	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	1830.70	4.81	2.17	2.63	1.60	2.40	1.72	0.80	1.26
Anulus Pulposus Cell, donor2	11463-119B5	1597.77	4.65	2.94	1.22	1.96	1.47	1.22	0.49	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1641.72	9.44	3.59	4.49	3.59	2.25	0.90	1.35	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1652.34	4.34	3.91	8.25	2.60	3.04	0.87	2.60	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	1902.68	14.98	8.56	8.56	2.14	8.56	6.42	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	1480.26	10.16	3.29	4.78	2.39	3.29	1.79	1.79	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1851.45	11.38	6.32	10.12	8.85	7.59	0.00	1.26	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1853.48	5.94	3.96	8.58	7.26	3.30	1.98	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1546.78	10.72	2.60	4.22	1.95	2.60	2.60	0.32	2.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1628.65	4.85	5.34	7.77	0.49	2.91	1.94	0.00	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1762.63	14.85	7.13	12.47	7.13	4.75	3.56	2.38	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1560.03	10.55	4.52	7.16	4.90	3.39	1.13	1.13	3.39
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1444.09	5.08	1.45	2.90	1.45	1.45	1.45	0.73	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1574.74	12.54	10.03	7.52	3.76	7.52	2.51	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1826.43	2.80	2.47	3.79	1.48	2.31	1.65	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1565.43	5.46	2.73	4.09	1.36	6.82	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1383.06	2.87	1.06	3.32	0.90	2.26	1.06	0.45	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1503.95	4.82	4.82	7.50	2.14	2.14	3.75	0.54	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	1594.05	6.80	3.21	5.29	3.02	2.83	2.08	0.94	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	2150.58	12.03	3.47	4.28	1.60	2.14	1.34	1.60	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1176.40	4.88	4.88	5.85	3.90	4.88	0.98	0.98	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1508.16	6.63	3.48	4.31	2.32	2.32	1.00	1.16	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1804.69	12.01	7.20	6.00	4.80	3.60	2.40	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	1709.89	3.54	0.00	3.54	7.08	3.54	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	1483.22	5.49	4.29	3.09	1.72	2.57	2.06	1.03	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	2248.50	8.39	0.00	0.00	8.39	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1622.78	11.16	4.85	4.85	1.94	2.43	2.91	0.97	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1617.60	5.69	5.31	5.31	2.28	4.55	1.90	0.00	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1949.09	16.96	8.48	9.69	6.06	9.69	3.63	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1494.06	5.70	2.85	3.42	3.42	3.42	1.71	0.57	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	1575.95	8.12	2.99	3.85	1.28	4.28	1.92	1.07	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1869.86	6.97	4.65	4.90	1.55	4.39	2.06	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1501.46	3.28	2.82	4.22	0.47	1.41	1.88	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1411.28	8.36	4.82	3.22	1.29	2.25	3.54	1.61	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1855.69	6.42	2.14	5.71	4.28	5.71	3.57	0.00	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1368.20	10.53	2.34	3.51	2.34	2.34	0.00	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1820.59	7.83	3.31	3.91	3.01	2.11	2.11	1.20	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2128.88	11.88	4.75	9.50	11.88	5.94	5.94	1.19	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1560.77	8.14	3.56	6.61	2.54	7.63	2.54	1.02	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1542.65	11.21	6.37	4.58	5.09	6.11	3.82	0.51	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1585.88	10.17	2.54	8.26	1.27	4.45	1.27	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1489.65	7.34	3.02	3.88	2.59	3.02	0.86	0.00	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1516.31	6.14	4.45	4.66	2.96	3.81	1.91	0.42	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1711.76	5.22	4.93	6.67	1.16	2.90	0.87	1.16	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1510.63	6.61	2.83	5.67	1.89	1.89	1.89	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	1383.32	4.92	4.58	4.07	3.05	3.05	2.54	0.51	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2012.92	13.90	11.58	6.95	4.63	11.58	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	1415.42	6.34	2.11	4.23	6.34	0.00	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1532.62	5.15	1.29	4.50	2.79	2.57	1.72	0.86	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2181.63	9.63	3.61	3.01	3.61	1.80	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1565.11	10.21	1.46	8.75	5.10	2.19	0.73	2.19	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	1555.14	7.82	3.91	3.68	2.07	3.22	1.84	1.61	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2045.34	40.80	25.50	20.40	10.20	12.75	7.65	0.00	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1561.74	3.05	1.53	3.05	1.02	2.03	1.78	2.29	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1704.16	8.88	3.30	3.92	1.65	3.10	1.24	1.03	3.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	1774.80	8.57	3.67	4.90	1.53	3.98	1.53	1.22	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1585.57	5.74	4.30	11.95	5.74	5.26	5.26	1.43	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	1564.15	7.32	4.43	3.55	3.33	3.77	1.77	1.77	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1597.51	6.10	10.68	9.15	4.58	1.53	4.58	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1315.48	7.75	4.98	6.65	1.66	2.22	1.66	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	1693.89	7.94	3.44	5.56	2.65	3.44	1.85	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1680.94	7.27	3.63	6.18	3.27	4.00	1.09	2.18	0.73
Astrocyte - cerebellum, donor1	11500-119F6	3103.82	5.16	1.72	2.95	2.58	1.47	1.60	0.49	0.37
Astrocyte - cerebellum, donor2	11580-120F5	3078.82	8.04	4.28	4.62	2.57	4.45	2.57	0.68	0.86
Astrocyte - cerebellum, donor3	11661-122F5	1978.76	4.40	2.73	1.05	1.89	1.68	1.26	1.47	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	1443.84	1.39	1.05	3.14	0.35	1.39	4.18	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	2467.86	11.81	6.31	6.96	3.56	5.34	2.59	1.46	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	1631.52	5.82	2.68	4.18	2.09	2.54	2.83	1.04	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2161.36	11.93	6.88	1.72	3.90	1.83	2.52	1.61	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2058.25	7.39	4.26	2.26	3.38	1.13	1.63	1.13	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2113.20	7.06	2.62	1.14	3.41	1.14	1.71	0.34	0.34
Basophils, donor1	12241-129G9	383.67	0.26	0.78	1.83	0.26	0.00	0.26	0.00	0.26
Basophils, donor2	12242-129H1	390.38	1.44	1.08	0.72	0.00	0.72	0.00	0.00	0.00
Basophils, donor3	12243-129H2	398.36	0.29	0.73	0.59	0.59	0.73	0.15	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	1805.46	1.72	1.72	2.59	1.72	0.86	1.72	0.86	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	3851.33	10.52	6.86	6.86	5.94	3.66	5.49	0.91	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	2281.19	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3842.49	6.90	6.90	13.81	3.77	3.14	2.51	0.63	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	4423.73	13.52	4.57	10.40	4.37	5.41	2.50	1.25	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	2175.78	9.21	2.76	9.21	2.53	7.14	2.30	0.46	2.07
Bronchial Epithelial Cell, donor7	11769-123I5	1286.25	8.46	2.34	3.96	2.34	3.42	1.98	1.08	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1208.53	1.55	1.03	1.44	1.24	0.72	0.31	0.00	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	1928.21	3.26	2.10	3.03	2.33	0.93	1.16	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	361.67	0.64	0.64	0.32	0.32	0.32	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	299.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	552.28	0.00	0.56	0.00	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	612.85	2.60	0.93	0.37	0.74	0.56	0.00	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	573.43	1.76	0.44	1.54	0.88	1.10	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	512.88	1.13	2.55	0.57	1.42	0.85	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	518.20	0.38	2.27	3.03	0.00	0.76	0.76	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	454.32	0.00	1.64	0.66	0.33	0.33	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	1395.33	8.53	5.64	4.34	3.76	3.04	1.45	1.30	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	1148.43	6.03	3.32	1.51	2.11	0.91	1.21	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	1301.49	5.92	2.13	2.61	2.13	2.13	0.95	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1646.02	8.87	3.68	5.36	4.18	3.01	1.67	0.33	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1340.04	5.80	2.76	2.48	2.21	1.66	1.10	1.93	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1604.10	7.69	2.48	2.73	2.23	0.99	0.25	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1273.49	5.09	3.92	4.11	2.15	2.74	1.96	1.17	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1124.73	5.70	2.85	2.31	0.89	0.53	0.71	0.53	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1144.52	3.92	2.61	1.74	1.96	1.52	1.96	0.22	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1374.56	3.28	2.34	3.04	0.70	3.04	0.70	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1162.19	4.22	2.64	3.17	0.00	1.58	2.11	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1385.59	5.55	1.11	0.00	4.44	2.22	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1455.21	10.41	4.76	3.72	3.57	4.31	1.78	0.59	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1451.11	9.18	3.39	4.59	1.60	2.00	1.40	2.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1372.24	6.45	3.33	2.50	1.25	1.04	1.04	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1642.68	10.30	3.20	5.03	2.75	2.97	2.75	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1241.18	4.75	1.36	1.13	1.13	0.90	0.45	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1297.16	5.24	5.24	2.18	2.62	1.75	0.00	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1273.40	6.72	3.50	3.23	2.42	1.34	0.81	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	969.13	6.46	2.62	2.97	1.74	2.44	0.87	0.87	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1067.62	4.63	2.95	2.52	2.10	1.26	0.84	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1846.85	10.66	5.33	4.41	3.31	4.23	1.10	1.10	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1994.18	5.64	3.17	3.52	1.41	2.11	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1994.01	8.77	2.63	0.44	6.14	3.95	2.63	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1048.51	5.93	3.31	2.44	1.05	2.96	0.35	0.70	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1004.64	6.32	1.49	2.60	2.97	1.12	1.49	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1130.77	4.10	2.37	1.08	0.43	1.72	0.43	1.08	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1972.50	10.65	3.69	6.55	1.64	2.05	1.64	2.05	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1587.82	4.64	2.09	1.39	1.16	1.62	0.23	0.23	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1580.56	7.66	5.10	3.71	0.93	1.86	0.93	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	465.57	3.05	1.31	1.31	0.65	0.87	0.44	0.44	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	437.04	2.08	1.15	2.08	0.69	0.23	0.46	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	421.32	1.95	0.00	1.52	0.22	0.22	0.00	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	1061.71	2.96	2.49	2.02	0.47	1.40	1.25	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	917.06	2.45	2.27	2.79	1.05	0.87	0.35	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	824.99	1.78	1.78	1.78	0.89	0.45	0.67	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	244.46	0.26	0.26	1.28	0.26	0.77	0.00	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	270.06	0.66	1.10	1.10	0.00	0.66	0.22	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	360.03	0.21	0.63	1.68	0.00	0.42	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	189.00	2.03	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	221.70	0.68	0.68	1.36	0.68	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	219.55	0.00	0.00	2.07	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	276.65	0.53	1.07	0.00	0.00	0.00	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	211.75	0.54	1.07	0.00	0.00	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	211.99	2.11	0.70	0.70	0.00	1.40	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	231.38	0.00	0.00	0.78	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	188.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	273.69	0.82	0.00	0.82	0.00	0.82	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	280.02	0.73	0.73	0.00	0.73	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	287.25	1.01	0.50	0.50	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	54.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	42.75	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	88.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	158.99	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	416.71	2.63	0.00	0.75	0.00	0.38	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	418.27	0.45	0.23	0.45	0.23	0.68	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	341.35	0.36	0.36	0.36	0.36	0.00	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	391.30	2.45	0.61	1.84	1.22	1.84	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	433.70	1.52	1.22	0.91	0.91	0.00	0.61	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	447.94	1.02	1.28	2.30	1.28	1.02	0.77	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	479.96	0.45	1.35	1.12	0.22	0.90	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	453.04	1.44	1.44	1.15	0.86	0.29	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	200.54	0.47	0.95	0.47	0.00	0.95	0.47	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	227.55	2.81	0.70	0.00	0.00	0.00	0.70	0.70	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	375.77	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	683.85	3.32	2.60	2.89	0.87	0.58	0.72	0.87	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	715.47	2.54	2.20	2.03	1.53	1.36	0.17	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	597.59	2.42	1.77	1.13	0.81	0.32	0.48	0.48	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	325.46	1.79	0.00	0.90	0.45	1.79	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	381.88	1.75	1.40	1.05	0.35	1.40	0.35	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	439.98	0.88	1.32	0.00	0.00	0.00	0.88	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	738.29	2.11	0.42	1.69	1.26	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	589.86	1.45	0.83	1.45	1.25	1.45	0.21	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	643.86	1.67	2.34	2.34	1.00	0.67	0.33	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	429.93	1.36	0.54	1.63	1.09	0.54	0.00	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	395.53	0.54	0.54	0.54	0.54	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	469.83	0.00	0.00	3.59	0.00	1.79	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	944.20	3.34	1.85	2.78	1.30	0.93	1.11	0.93	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	555.41	0.87	0.87	1.08	0.65	0.43	0.22	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	462.33	0.84	0.84	1.26	0.63	0.42	0.63	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	339.77	1.01	0.51	2.53	0.00	0.00	0.00	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	319.31	0.87	0.00	0.87	0.43	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	414.90	1.31	0.44	1.74	0.44	1.31	0.44	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	371.15	0.99	0.49	0.49	0.00	0.49	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	278.80	0.92	0.92	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	266.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	449.73	1.38	0.55	0.83	0.28	0.55	0.00	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	482.68	0.74	0.49	0.25	0.00	0.25	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	535.92	0.00	0.00	1.54	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	433.32	0.72	0.36	0.72	0.72	0.72	0.36	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	335.17	1.38	1.38	1.38	0.00	0.00	1.38	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	197.75	0.33	0.33	0.33	0.33	0.33	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	208.74	1.50	0.75	0.38	0.75	0.38	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	234.31	1.77	1.01	0.76	0.00	1.01	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1547.93	8.49	3.90	1.38	2.06	2.29	1.15	0.69	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1403.35	9.11	4.79	3.12	1.92	3.12	1.68	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1426.23	10.67	4.65	4.92	5.47	3.28	1.09	1.64	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1651.76	5.70	5.10	6.60	2.70	3.00	1.50	2.10	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1190.55	6.24	5.52	0.72	1.20	1.44	1.92	0.96	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	1536.90	4.09	2.73	1.82	1.82	1.14	0.91	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1939.04	6.74	5.43	3.26	1.74	1.96	1.09	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2108.79	8.95	3.16	2.90	4.21	2.11	1.58	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1813.51	8.44	3.99	3.05	3.28	1.41	0.94	0.94	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1989.67	9.36	4.83	3.92	5.74	2.11	1.81	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2002.74	10.17	4.65	4.94	2.91	2.32	2.61	0.58	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2016.64	5.86	2.93	4.53	4.00	3.46	1.87	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1565.83	1.31	2.19	1.75	2.63	0.44	1.75	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1478.78	0.46	0.91	0.91	2.28	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1708.79	0.75	2.24	0.00	1.49	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1630.06	5.04	3.60	2.16	2.16	1.08	0.36	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1400.63	2.59	1.73	2.88	2.59	1.73	1.73	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1385.90	3.30	3.54	1.89	3.30	2.12	0.94	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1706.84	6.34	6.02	2.85	2.54	2.85	2.54	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1934.57	3.69	4.61	4.31	2.46	2.77	3.38	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	1747.82	5.13	3.53	2.56	2.24	1.60	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1736.39	5.74	3.06	4.59	3.82	1.15	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1612.68	7.49	3.55	3.15	0.79	0.79	1.18	0.79	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	1722.35	9.08	5.29	4.54	1.51	2.27	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	753.17	0.80	3.21	0.00	0.00	1.61	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	760.98	1.40	1.40	1.40	0.00	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	800.40	2.00	0.00	0.00	1.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	1114.92	0.00	0.00	0.00	1.83	0.00	3.66	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	1466.46	4.45	3.95	1.98	1.98	3.46	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	1363.50	1.68	0.95	0.32	0.74	0.84	0.32	0.21	0.53
Chondrocyte - de diff, donor1	11261-116G1	1588.78	5.20	3.12	1.73	4.51	2.43	0.69	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	1714.69	3.20	3.91	3.20	1.07	2.84	0.36	0.00	1.07
Chondrocyte - de diff, donor3	11410-118E6	1373.54	7.85	4.44	2.28	4.78	1.25	1.59	1.14	1.02
Chondrocyte - re diff, donor2	11339-117F7	2110.12	0.90	2.69	4.48	2.69	5.37	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	1665.33	5.66	6.47	6.07	3.24	4.85	1.21	1.62	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	1946.41	4.36	2.75	3.33	1.38	3.33	1.26	0.46	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	1733.43	7.91	4.28	5.99	1.28	6.84	1.92	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	1653.32	5.58	4.25	3.63	2.12	2.65	2.04	1.68	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	498.48	0.92	1.56	0.46	0.55	0.55	0.73	0.00	0.09
Corneal Epithelial Cells, donor1	11526-119I5	2612.03	2.63	1.76	2.42	1.54	1.32	1.10	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3388.91	10.24	5.69	5.69	4.55	2.28	5.69	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	2456.87	6.39	5.37	6.39	2.30	3.58	2.81	1.53	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1217.41	2.15	1.65	1.98	1.49	0.99	0.66	0.83	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1118.76	1.26	2.84	2.52	3.15	2.21	0.63	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	755.70	0.00	3.45	0.00	0.00	3.45	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1560.56	8.10	3.78	4.54	3.13	3.78	2.27	1.51	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	229.58	0.00	0.00	0.34	0.68	0.00	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	196.51	0.65	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	179.54	0.48	0.48	0.48	0.00	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	1250.93	2.00	1.67	1.83	1.17	2.33	0.33	0.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	1366.60	2.35	1.17	1.17	1.17	1.17	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	1264.10	1.13	1.98	1.13	3.96	1.41	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	1356.88	1.18	1.18	5.50	1.57	1.97	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	1071.87	2.91	1.45	0.29	2.04	1.16	1.16	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	1100.87	9.41	4.24	0.00	3.29	1.41	1.18	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	1644.22	6.49	2.98	3.33	3.16	3.68	1.23	1.93	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	812.13	3.10	1.33	1.77	0.44	1.77	0.44	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	734.20	1.52	0.91	1.22	0.91	1.52	0.91	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	637.10	0.85	0.28	1.41	0.56	0.28	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	829.89	1.49	0.59	0.59	2.67	0.30	0.89	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	967.39	4.69	0.52	0.00	1.04	1.04	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	342.70	2.13	1.13	0.28	1.70	0.14	0.57	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	1484.84	1.20	0.80	2.40	4.80	0.00	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	874.24	7.34	0.52	1.05	1.05	0.00	2.10	0.52	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1051.87	3.11	1.99	1.74	0.87	1.99	0.37	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	757.81	1.09	0.87	1.96	1.09	1.09	0.00	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	942.46	1.34	1.22	1.34	3.18	0.85	0.24	0.24	0.49
Endothelial Cells - Vein, donor1	11267-116G7	1518.57	1.14	1.14	1.14	3.41	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	1600.96	2.10	2.10	3.49	0.70	3.49	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	1119.15	3.30	1.41	2.51	1.57	2.20	0.94	1.26	0.31
Eosinophils, donor1	12244-129H3	548.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	171.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	263.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2300.33	3.42	3.18	2.44	1.71	1.95	0.98	0.24	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	1813.90	4.16	2.08	0.00	0.00	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	4018.39	16.27	0.00	0.00	0.00	16.27	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1888.37	4.52	4.11	3.69	3.69	4.11	2.46	1.64	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1594.15	12.26	27.92	20.91	17.52	15.77	11.61	3.39	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1289.76	8.88	11.48	6.61	5.96	2.49	3.25	1.63	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1491.62	5.46	4.37	5.22	3.03	1.94	1.21	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	4249.72	8.05	4.23	5.19	3.55	2.46	2.59	0.82	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1726.00	9.49	10.34	5.17	8.23	3.80	2.53	1.27	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	2050.48	3.16	1.84	4.22	3.16	1.32	1.05	0.26	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	1523.47	8.30	8.97	5.32	3.32	2.99	1.99	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	2056.29	6.35	2.27	5.44	2.72	4.99	0.91	2.27	0.45
Fibroblast - Cardiac, donor2	11345-117G4	1907.76	7.58	2.27	5.31	3.03	0.76	1.52	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	1481.11	8.67	6.15	1.89	4.42	1.58	2.52	0.79	1.10
Fibroblast - Cardiac, donor4	11452-119A3	839.31	1.82	1.21	0.91	0.30	0.91	1.52	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	985.66	3.05	2.16	2.79	0.89	1.90	0.13	0.63	0.63
Fibroblast - Cardiac, donor6	11460-119B2	1162.12	4.40	1.36	3.94	0.61	1.67	0.45	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	1362.28	2.14	1.07	1.61	1.47	1.07	0.54	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	978.91	2.16	0.86	0.86	1.73	1.73	0.00	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	1236.28	10.25	2.93	0.00	1.46	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	1376.22	1.15	2.08	1.15	0.69	0.46	0.46	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	412.82	0.34	0.34	0.17	0.68	0.51	0.17	0.17	0.51
Fibroblast - Dermal, donor1	11269-116G9	1329.80	3.76	4.46	0.94	4.70	1.64	0.70	0.94	0.47
Fibroblast - Dermal, donor2	11346-117G5	1758.42	1.89	1.89	2.36	0.47	0.00	1.89	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	1081.57	6.04	3.99	0.97	2.54	1.57	1.33	0.73	0.48
Fibroblast - Dermal, donor4	11450-119A1	1500.56	6.22	2.37	3.50	1.81	3.39	1.36	0.57	0.57
Fibroblast - Dermal, donor5	11454-119A5	1730.58	4.54	1.22	4.01	1.22	2.62	1.40	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	2030.62	5.20	1.62	5.20	2.11	1.62	0.97	0.49	0.32
Fibroblast - Gingival, donor1	11237-116D4	1703.94	3.33	1.67	3.12	1.04	0.83	1.25	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	2260.27	4.72	4.98	6.81	5.24	2.10	1.57	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	1787.91	14.10	5.80	3.03	1.84	4.48	2.24	2.24	0.92
Fibroblast - Gingival, donor3	11394-118C8	1173.39	2.42	1.93	1.26	1.45	1.16	0.58	0.58	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	1160.44	1.04	5.19	2.08	4.16	2.08	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	927.89	5.46	3.52	4.76	3.00	1.94	1.94	0.88	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	2148.25	5.46	4.68	4.37	2.96	2.49	2.03	1.09	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	2862.76	6.76	5.68	6.76	5.41	3.92	1.89	1.08	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1887.90	1.06	2.47	3.18	3.18	1.76	1.06	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	2525.50	3.07	3.51	4.68	3.51	2.05	1.02	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	2741.11	5.18	4.36	5.32	4.23	1.64	1.23	0.95	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	2007.49	3.62	3.62	4.28	1.76	1.43	0.88	0.44	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	989.17	2.05	2.93	3.82	1.91	1.17	0.88	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	2682.00	10.87	1.36	5.44	2.72	1.36	4.08	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	1223.57	4.48	1.49	0.00	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	1519.67	6.96	6.96	1.06	2.53	1.90	1.48	1.69	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	4649.93	3.33	2.50	4.17	2.50	3.33	3.33	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	1874.16	4.20	1.40	1.40	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2450.03	3.36	2.52	3.08	1.96	2.80	0.84	0.28	1.68
Fibroblast - Mammary, donor1	11540-120B1	2416.73	0.81	2.44	1.22	0.41	0.81	1.22	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	3698.64	11.98	3.99	0.00	3.99	0.00	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	2174.04	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1681.17	4.66	1.16	3.10	0.78	1.55	1.16	0.58	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1781.65	6.98	4.25	1.52	3.03	1.97	1.82	0.61	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1408.46	1.22	1.53	3.06	0.92	1.22	0.00	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	1939.79	1.91	3.43	1.53	2.67	0.00	1.14	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	1688.25	15.12	4.59	5.40	3.78	4.05	2.43	1.35	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	933.48	2.55	3.71	2.90	3.13	1.51	1.16	0.58	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	1328.60	3.32	2.43	1.77	1.33	1.22	1.22	0.66	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3003.36	2.03	2.24	4.06	3.05	1.83	1.42	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2155.62	5.35	3.34	2.00	2.67	4.01	2.67	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1245.78	2.77	1.58	1.19	1.98	1.19	0.79	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	4531.35	9.53	3.37	5.36	3.77	1.59	1.79	0.79	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	1259.49	3.02	0.71	1.42	0.89	1.60	0.36	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1803.13	3.15	1.77	2.96	2.17	1.38	1.38	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	3911.11	5.11	1.50	4.21	1.50	1.81	1.50	1.20	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1929.96	6.59	1.94	3.35	3.02	1.30	0.86	0.00	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4855.23	13.92	5.82	5.82	5.06	3.80	2.02	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	2335.65	4.59	2.30	4.10	3.45	1.31	0.49	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	2822.94	7.62	3.01	2.01	1.00	2.01	2.41	0.80	0.40
Fibroblast - skin normal, donor2	11561-120D4	1868.90	5.63	2.11	2.71	2.81	1.61	0.40	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	5292.78	10.58	4.23	7.86	2.72	2.12	2.42	0.30	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	1520.72	4.14	1.66	2.40	1.49	1.74	0.99	0.50	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	1014.08	2.91	1.03	1.54	2.05	0.34	0.68	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	4102.44	9.20	2.30	4.60	2.30	1.97	2.96	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	2324.63	7.46	3.09	4.47	2.13	2.56	0.85	0.11	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	2767.38	5.06	2.53	2.53	2.19	1.52	1.52	1.18	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1307.41	21.80	10.51	5.65	4.23	5.49	3.29	3.76	3.14
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	8841.76	265.92	44.32	110.80	0.00	110.80	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	949.10	1.74	0.87	3.49	2.61	0.00	2.61	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	2414.35	5.72	3.29	6.24	4.33	4.16	1.73	0.69	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	2552.18	4.94	7.29	4.16	4.16	3.90	1.30	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	2169.05	3.58	4.85	3.32	4.85	2.81	1.02	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1738.57	6.12	9.95	6.12	8.42	3.06	3.06	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1837.01	7.02	8.93	7.66	3.19	5.10	1.91	3.19	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1048.91	4.28	3.71	1.43	3.42	0.29	0.86	0.57	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1035.47	2.76	8.27	4.69	5.79	2.76	1.65	0.55	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1198.94	2.51	8.68	4.11	6.39	1.60	1.60	1.14	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1077.83	2.77	5.15	2.18	3.37	0.40	1.19	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	855.92	4.76	6.87	3.70	2.91	2.38	0.79	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	945.83	1.30	3.91	2.61	3.91	1.63	0.98	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1738.38	4.86	5.31	2.65	3.98	1.77	2.21	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1450.25	4.80	4.38	3.11	3.96	0.85	1.55	1.70	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	1192.63	4.68	4.19	3.69	1.35	1.97	1.35	1.48	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1212.04	6.98	4.84	1.88	4.03	2.42	1.61	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	1776.39	4.83	5.33	2.35	5.82	2.11	1.98	1.49	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	2084.98	5.40	6.37	4.01	4.84	0.97	2.21	2.63	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1908.00	9.96	4.88	3.05	3.05	2.24	1.42	2.24	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	1494.34	4.56	3.19	1.37	5.70	3.19	0.46	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	1869.11	6.85	4.73	3.86	5.98	1.49	1.74	1.87	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	2045.44	6.34	4.37	2.40	4.59	1.09	1.53	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	986.31	2.66	4.43	1.48	3.55	0.30	0.00	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	1446.68	4.45	4.29	3.66	4.61	1.27	1.43	1.75	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	1305.44	4.47	4.47	1.34	4.47	1.34	0.45	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	1377.56	5.44	6.86	1.81	4.23	1.81	1.41	1.81	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1664.19	5.77	4.41	2.37	4.07	1.87	1.53	2.37	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1779.38	4.88	3.46	0.80	4.26	1.51	1.24	0.27	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1322.34	3.95	3.85	1.87	4.89	1.25	0.62	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1489.51	3.07	4.44	1.37	6.15	0.85	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1349.20	2.43	3.21	1.44	3.21	0.89	1.00	0.89	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1429.89	2.91	3.00	1.00	3.00	1.16	0.92	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1780.46	3.47	3.47	1.23	3.47	1.02	0.82	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1171.40	8.25	4.75	0.62	2.89	1.24	0.83	0.83	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	1292.09	2.77	2.88	1.50	4.27	0.92	1.04	0.58	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	1221.55	4.00	3.00	1.83	3.34	2.67	1.00	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	986.65	4.19	4.63	1.32	3.97	0.44	1.76	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	899.32	3.32	3.81	1.48	1.97	1.84	1.11	1.11	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	1252.17	6.97	3.73	0.97	2.43	0.97	1.46	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	754.96	4.49	4.17	0.32	1.28	0.96	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	1434.49	3.03	4.26	3.22	3.13	1.80	1.80	1.52	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	1348.93	4.11	4.59	3.16	2.85	1.74	1.90	0.95	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	1467.22	10.03	4.26	3.04	3.34	2.13	1.82	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	1544.76	6.27	5.54	2.09	3.35	1.36	1.46	0.84	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	1137.95	3.07	2.20	1.54	3.29	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	1411.44	5.89	4.49	3.93	2.24	1.40	0.84	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	1247.24	4.07	3.33	2.04	1.48	1.11	0.74	1.94	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	1237.54	5.88	3.21	2.94	2.67	2.14	0.80	1.60	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	1432.89	5.20	2.30	1.53	2.91	1.38	1.22	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	1345.11	2.07	4.66	2.46	1.55	0.65	0.78	2.33	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	808.34	3.52	2.44	0.54	2.17	0.27	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	1122.33	5.35	4.61	0.92	1.66	1.29	1.11	2.21	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	910.15	3.95	3.51	1.54	1.75	1.54	2.19	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	613.89	0.99	0.99	0.00	0.99	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	1421.35	4.35	4.49	1.06	2.11	1.06	1.32	1.06	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	1323.73	6.66	4.84	1.61	3.63	2.02	2.02	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	995.29	0.51	1.78	1.27	4.07	0.51	0.76	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1505.49	3.58	3.18	2.79	3.18	1.39	2.39	0.20	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	904.58	2.93	3.85	2.31	3.08	1.69	1.23	1.08	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1078.77	1.64	2.86	1.23	1.84	0.41	0.61	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1173.80	1.88	1.88	2.19	1.56	1.56	0.63	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1296.93	2.54	2.83	2.54	3.67	0.57	1.13	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1025.72	1.38	1.38	4.15	2.31	0.92	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	935.47	2.47	2.47	0.00	0.00	0.00	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1209.55	5.42	4.64	2.32	4.25	2.32	1.93	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1633.35	6.42	1.60	1.60	3.21	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1241.52	6.96	8.69	3.48	5.22	1.74	3.48	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1156.75	5.53	5.21	1.63	3.58	2.93	1.30	1.30	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1054.62	3.71	2.47	3.71	2.88	0.41	0.82	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1029.67	36.65	10.00	0.00	6.66	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1311.83	4.47	5.31	2.80	1.96	1.96	1.96	1.68	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1298.22	3.60	4.90	1.96	4.90	0.65	2.29	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1260.77	6.71	5.03	1.68	2.52	3.36	1.68	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1533.43	7.95	5.41	3.50	2.86	0.64	0.95	0.95	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1459.53	4.08	3.06	3.74	3.06	1.70	2.38	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1035.72	4.18	4.18	0.00	0.00	4.18	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1696.34	6.87	5.73	1.72	3.44	2.29	0.00	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1401.18	5.33	5.92	1.78	2.37	2.37	3.26	0.59	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1241.81	15.25	5.08	5.08	6.78	1.69	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1629.08	16.57	4.97	2.49	3.73	2.07	2.07	1.66	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1625.40	7.82	4.37	3.22	4.37	0.92	0.92	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	1116.92	10.54	0.00	5.27	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1199.37	8.07	8.84	1.54	3.84	1.15	1.92	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1202.83	6.19	2.61	1.96	3.59	1.30	0.98	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	964.47	1.34	4.01	1.34	3.34	1.34	1.34	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	948.14	5.78	2.70	1.93	3.08	0.39	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1108.50	4.45	4.45	2.05	1.71	2.40	0.68	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	524.29	4.97	4.97	0.00	0.00	0.00	0.00	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	853.58	0.94	2.83	0.47	0.94	1.42	0.00	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	710.31	4.83	1.81	1.21	1.81	1.21	0.60	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	820.49	1.02	4.58	1.53	2.03	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	862.69	3.99	5.18	1.99	3.19	1.20	1.20	2.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	694.64	2.47	0.99	1.48	1.97	0.49	1.48	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	721.25	4.72	2.36	1.18	2.36	2.36	1.18	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	766.65	4.08	2.92	0.58	1.17	0.58	0.58	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	531.49	3.51	2.19	0.88	1.76	0.88	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	602.71	4.24	5.93	2.54	2.54	0.85	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1079.22	4.78	3.58	0.60	2.98	2.39	2.39	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1360.15	9.22	5.82	1.94	7.28	0.97	1.46	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4299.29	13.70	3.42	5.71	3.42	9.13	2.28	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2033.34	14.55	8.32	2.49	3.74	2.91	2.49	1.25	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4657.49	7.87	2.25	7.87	5.62	4.50	3.37	1.12	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	684.75	2.85	2.54	0.32	0.32	0.32	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	1159.23	5.01	1.25	1.25	0.84	1.67	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	1986.06	10.91	7.66	3.02	4.76	3.02	2.32	1.86	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	2457.24	14.69	8.44	2.70	5.06	4.05	3.71	0.84	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	2206.55	11.38	4.78	2.28	3.19	2.50	2.28	0.68	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2042.76	14.76	8.64	4.15	5.03	4.92	3.72	1.31	1.42
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2455.16	9.89	7.74	4.51	2.36	2.79	2.58	1.29	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2233.77	8.18	6.67	3.01	2.58	1.94	2.15	0.43	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1981.77	11.71	12.20	4.86	2.99	3.49	3.11	1.37	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2125.84	6.00	6.00	2.57	3.95	2.23	5.15	1.20	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2112.86	8.01	4.16	4.49	1.92	2.24	1.28	1.60	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	894.28	0.56	2.24	1.12	1.68	1.12	1.68	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2335.79	3.46	5.63	1.73	2.60	1.30	0.87	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	1713.19	21.15	0.00	2.64	5.29	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1239.11	1.41	1.76	2.12	1.76	1.06	1.06	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1094.13	2.91	3.63	1.45	2.18	0.73	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	1215.65	8.22	4.20	3.32	1.57	2.10	2.27	0.87	1.75
Hepatocyte, donor1	11523-119I2	13.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	80.80	0.00	0.00	0.00	0.00	0.00	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	75.47	0.61	0.00	0.61	0.61	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1150.69	3.26	1.31	1.96	1.31	2.61	0.00	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	655.08	3.50	1.92	0.70	0.87	1.05	0.87	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	2069.76	3.98	2.20	1.37	1.51	1.51	1.23	0.82	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	1009.29	0.00	0.00	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	1054.70	13.35	0.00	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1679.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	948.30	2.77	0.00	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	1366.45	10.01	0.00	2.50	0.00	0.00	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1625.95	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	943.15	5.13	2.56	0.00	0.00	2.56	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	1202.11	4.57	4.57	4.57	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	989.22	0.00	6.50	4.87	0.00	0.00	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1167.11	10.00	0.00	1.67	3.33	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	1267.07	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1087.89	6.62	1.32	1.32	0.00	0.00	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	981.15	3.33	5.54	1.11	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	1561.01	0.00	0.00	0.00	5.24	10.48	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	728.12	5.67	1.26	1.89	1.89	0.63	1.26	1.26	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1020.77	0.00	0.00	0.00	0.00	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	1214.68	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	865.04	1.29	1.94	1.29	2.58	0.65	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1059.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	1648.85	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	869.47	4.07	4.07	0.81	4.89	0.81	1.63	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1158.26	3.78	1.26	2.10	1.68	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	1149.79	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	812.53	0.80	2.41	1.61	1.61	0.80	1.61	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	974.06	5.54	0.92	0.92	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	919.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	728.35	3.30	3.30	1.42	1.42	0.00	2.83	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	779.10	3.63	1.81	2.72	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	1297.34	0.00	0.00	14.74	14.74	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	824.31	4.30	3.23	4.30	2.15	0.00	2.15	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1151.04	1.27	2.54	1.27	2.54	0.00	0.00	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	1281.57	16.43	0.00	16.43	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	911.24	0.64	1.28	0.64	0.64	0.64	3.19	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1128.23	1.82	5.47	0.00	0.00	0.00	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	1169.52	0.00	0.00	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	802.61	4.28	3.57	5.71	1.43	0.71	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	1138.18	3.32	3.32	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	1292.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	723.19	1.54	2.78	1.23	1.23	0.31	1.23	1.23	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1025.52	0.00	0.00	0.00	0.00	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	1109.52	0.00	0.00	0.00	3.14	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	806.65	2.09	1.39	0.70	2.09	0.70	2.09	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	1049.01	0.00	4.43	0.00	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	917.49	3.24	6.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	769.04	2.62	4.36	1.74	0.00	0.00	0.87	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	735.68	0.00	6.75	2.25	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	658.58	3.48	0.00	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	533.39	0.00	1.07	1.07	0.00	0.00	1.07	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	665.01	1.39	0.00	0.00	0.00	4.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	809.29	0.00	2.85	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	705.05	1.84	3.68	3.68	0.00	0.92	0.00	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	532.46	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	596.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	478.99	2.11	4.23	1.06	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	3234.18	6.53	5.96	3.10	8.73	2.77	2.12	0.41	0.08
Keratinocyte - epidermal, donor2	11349-117G8	2224.83	2.93	1.17	3.51	1.17	1.76	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	2129.00	7.67	5.77	2.18	2.65	3.22	2.65	1.70	1.23
Keratinocyte - oral, donor1	11251-116E9	2018.79	6.02	4.31	1.02	2.38	1.02	1.36	1.14	0.23
Keratocytes, donor1	11527-119I6	667.72	1.03	0.69	0.69	0.00	0.34	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	2793.57	5.86	2.34	5.86	4.69	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	417.92	0.40	0.99	0.00	0.79	0.20	0.59	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	3318.85	0.00	2.20	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2346.27	11.87	1.08	2.16	0.00	1.08	2.16	3.24	4.31
Lens Epithelial Cells, donor2	11609-120I7	1797.10	2.19	0.92	1.04	0.58	1.61	1.04	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	1130.89	0.61	0.20	0.50	0.81	0.50	0.61	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	619.80	2.02	1.90	1.90	0.95	0.95	1.42	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	487.26	2.51	1.67	1.12	1.95	0.56	0.28	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	465.15	3.31	1.42	1.89	1.10	1.10	0.63	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	560.84	2.69	2.69	1.08	1.08	1.61	0.54	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	600.39	2.84	1.26	2.52	1.89	0.95	1.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	458.00	3.23	2.37	1.40	0.97	0.97	1.29	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	465.38	0.82	0.82	0.82	0.41	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	551.65	2.53	1.52	1.01	0.25	0.00	1.01	0.25	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	476.30	1.83	0.56	0.99	0.99	0.70	0.56	0.70	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	541.48	1.58	1.58	0.00	2.37	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	503.13	2.91	1.36	2.13	0.78	0.78	0.00	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	504.16	3.52	2.41	0.74	1.11	0.93	1.11	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	498.59	1.74	1.05	1.05	1.05	0.35	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	545.50	1.19	3.10	2.15	1.19	0.72	0.72	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	484.70	2.75	1.65	1.51	1.37	0.82	0.69	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	553.09	1.54	2.16	0.92	1.23	1.54	0.92	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	533.08	1.25	1.56	1.25	0.31	0.94	0.62	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	523.17	1.83	1.10	1.46	0.91	1.65	0.91	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	518.68	1.65	1.65	0.99	1.65	0.99	1.65	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	601.85	2.93	1.76	0.88	0.88	0.29	0.88	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	630.54	3.24	1.74	2.24	1.99	2.49	1.24	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	546.07	1.94	1.94	0.48	0.97	1.45	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	544.52	1.89	2.42	2.96	0.54	1.35	0.27	0.81	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	482.74	2.88	1.06	1.36	1.06	0.76	0.61	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	584.25	2.59	1.56	0.52	0.52	1.04	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	541.07	2.09	2.09	0.00	1.26	1.05	0.84	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	470.21	3.46	0.75	0.75	1.65	0.30	0.60	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	599.83	2.06	0.69	1.38	0.69	2.06	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	551.84	1.32	0.38	1.32	0.56	1.69	0.75	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	478.19	3.39	1.48	1.06	1.06	0.53	0.42	0.42	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	532.07	0.97	1.45	0.00	0.97	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	564.00	1.65	0.99	1.98	0.99	0.33	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	484.91	1.98	2.11	0.99	1.49	0.99	0.99	0.37	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	527.18	1.11	0.74	2.59	2.59	2.59	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	535.67	3.21	1.48	0.99	0.74	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	483.29	2.75	1.65	0.27	1.37	0.96	0.55	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	482.78	1.29	1.61	2.57	0.32	0.96	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	601.96	2.13	0.91	1.83	0.30	0.61	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	489.18	2.52	1.12	0.98	0.28	0.42	0.42	0.14	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	473.25	2.13	0.71	0.71	1.78	0.71	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	781.94	1.45	2.42	1.45	1.45	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	564.08	2.96	2.18	1.24	1.71	0.93	0.78	0.78	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	555.78	2.86	1.07	0.72	0.36	1.07	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	593.89	0.98	1.96	1.63	0.33	0.65	0.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	573.02	2.35	2.12	1.18	1.18	0.71	1.18	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	656.01	1.61	1.49	1.49	1.61	0.87	1.24	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	616.24	1.79	1.02	1.79	2.31	0.26	1.02	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	439.78	3.88	2.69	0.30	1.19	0.60	0.30	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	1339.21	6.80	2.27	0.00	4.53	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1874.87	10.74	4.60	6.90	1.53	6.90	2.30	2.30	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1923.85	7.42	5.94	2.23	2.23	3.71	0.74	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2389.83	19.46	13.12	13.54	5.50	8.89	3.81	1.69	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1660.55	11.96	4.22	1.41	2.11	3.52	2.81	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1916.50	5.60	0.93	2.80	0.93	1.87	0.00	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2162.07	32.98	8.76	12.88	6.18	11.34	3.09	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2036.36	10.71	8.33	3.57	8.33	2.38	0.00	4.76	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1752.09	5.20	4.75	2.49	1.81	2.26	1.58	0.23	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2002.64	21.23	5.23	6.40	4.36	4.65	2.62	1.74	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1791.70	18.01	3.60	5.85	4.05	6.75	0.45	2.25	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2082.83	5.96	4.74	4.88	3.39	2.57	1.08	0.68	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	2419.21	13.35	8.22	10.78	3.08	5.65	4.62	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1755.45	9.88	4.94	2.82	2.47	1.41	1.76	1.41	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1648.44	5.33	3.33	2.67	1.33	0.00	2.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	2141.97	15.79	8.15	9.17	3.06	9.17	2.55	3.06	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1750.25	9.34	2.13	5.87	3.74	3.47	1.87	0.80	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1948.02	13.79	6.24	6.42	3.78	3.21	1.70	1.70	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	2282.45	11.66	4.91	11.66	3.68	7.36	3.68	3.07	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	2159.24	12.23	8.15	6.52	8.97	7.34	2.45	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1892.72	17.28	7.29	9.37	4.37	5.62	2.08	1.87	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	2219.67	23.82	9.53	10.93	5.04	7.29	2.80	1.40	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	2226.57	19.58	6.18	5.15	6.18	6.18	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1949.39	22.93	6.97	11.90	4.35	6.97	6.10	2.03	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	2101.78	18.83	7.47	5.98	2.09	6.28	2.09	0.60	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1770.97	9.96	5.53	7.75	4.43	5.53	2.21	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	2287.42	23.68	8.13	9.54	4.24	7.42	5.66	2.83	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	2398.18	13.64	9.59	9.22	4.06	6.64	2.95	2.58	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2204.69	5.76	6.91	6.91	4.61	2.30	2.30	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	2432.61	21.11	6.91	8.06	7.29	6.14	2.69	1.92	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	2619.49	31.14	8.49	9.06	9.06	8.49	3.96	3.96	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	2176.70	2.46	5.74	4.92	3.28	3.28	0.82	3.28	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	2376.91	18.98	9.94	4.52	5.42	5.87	4.07	1.81	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2836.67	33.03	8.62	12.21	7.18	7.18	2.87	0.00	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2066.68	7.47	5.98	2.99	2.24	1.49	1.49	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	2506.77	26.75	10.40	13.01	4.83	7.80	4.83	3.72	3.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	2524.61	12.06	6.89	6.03	3.02	4.74	3.45	1.29	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	2384.79	12.84	5.99	1.71	3.43	1.71	2.57	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	2456.18	21.66	10.33	5.66	7.66	5.33	4.66	1.33	2.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	2697.99	19.31	9.65	5.43	3.62	5.43	3.62	2.41	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2045.54	13.51	5.69	5.69	5.69	4.98	1.42	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	2199.11	21.65	6.19	7.22	6.87	8.59	3.78	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	2846.91	26.84	10.20	13.42	4.83	9.12	3.76	2.15	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2049.71	12.79	6.73	7.41	6.73	1.35	0.67	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	2373.94	27.04	12.59	9.63	10.00	8.89	2.59	1.85	4.07
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1626.94	6.98	3.49	12.79	2.33	4.65	2.33	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2009.71	11.64	4.23	3.17	3.17	2.12	0.00	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	2369.69	19.21	13.20	7.60	5.20	5.20	5.20	2.00	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2432.84	10.18	2.91	8.00	3.63	5.81	0.00	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1911.69	13.03	6.90	11.50	3.83	4.60	1.53	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2230.11	17.76	11.35	12.33	6.41	2.47	1.97	2.96	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	2214.01	13.17	7.53	5.65	6.59	0.94	0.94	0.94	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1831.78	12.07	5.53	4.02	4.53	2.01	3.02	1.01	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	2146.32	18.02	9.01	6.76	4.06	3.15	4.06	2.25	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	2750.32	24.10	10.33	3.44	3.44	1.72	3.44	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1945.70	18.70	6.68	5.79	4.90	1.78	1.78	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	2198.35	18.38	8.99	6.26	4.69	5.87	1.56	1.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2434.42	13.85	7.92	10.56	3.96	3.30	3.30	2.64	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	2003.05	12.45	6.75	6.23	3.63	7.26	2.59	0.52	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2216.27	23.63	7.00	9.63	6.56	5.69	5.25	3.94	3.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2332.57	10.06	5.59	11.74	6.71	4.47	1.12	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1961.77	7.95	4.86	7.95	4.42	4.42	1.77	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	2198.96	16.59	8.49	11.19	3.09	6.56	1.54	3.47	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	2392.52	14.18	6.08	11.65	5.57	6.08	1.52	2.03	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	2130.59	12.50	3.36	3.36	5.77	4.33	1.44	1.44	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	2341.95	21.47	9.54	5.17	6.76	4.37	4.77	0.80	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	2542.29	12.76	6.08	11.54	1.82	6.68	3.04	1.22	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	2041.90	8.30	4.15	5.53	3.46	2.77	2.08	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	2244.99	20.90	8.74	7.22	3.80	6.84	5.32	2.66	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	2838.23	18.59	5.68	15.49	8.26	8.78	4.65	0.52	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	1951.22	7.26	6.05	7.26	4.23	5.44	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	2222.11	15.85	7.29	7.61	5.07	5.70	3.17	2.54	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	2712.36	14.39	5.33	4.26	3.73	3.20	1.07	1.07	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2180.30	6.90	3.45	6.90	4.02	3.45	2.87	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	2521.29	18.51	9.77	10.28	4.11	11.31	1.54	4.11	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3040.91	21.22	10.61	10.61	5.66	4.95	2.12	4.95	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2415.22	9.08	5.67	7.94	3.40	2.84	2.84	0.57	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	2435.41	23.71	8.32	7.49	4.16	5.41	3.74	2.91	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3373.34	25.06	4.70	16.44	9.40	5.48	6.26	1.57	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2250.58	7.52	7.93	6.26	5.01	4.18	2.92	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	2525.77	19.05	9.76	6.04	6.50	6.04	2.32	1.39	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	2937.12	18.73	6.69	7.36	4.68	2.68	6.02	4.01	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2617.61	6.42	2.14	8.55	4.81	4.81	3.21	0.53	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2622.18	26.27	9.70	8.49	7.68	8.89	6.06	4.04	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	2717.49	10.10	5.51	6.42	5.51	2.75	2.75	1.84	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2508.18	15.11	4.45	7.11	4.45	2.67	1.78	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	2603.16	15.39	13.68	6.84	5.13	1.71	2.28	2.28	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	2801.48	10.74	9.20	11.50	6.90	4.60	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2816.32	10.40	5.47	4.92	9.30	6.02	3.83	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	2547.51	19.15	10.69	8.46	5.79	4.01	2.23	0.89	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2689.50	7.80	6.50	4.68	3.38	2.86	1.30	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2822.85	14.59	5.97	5.97	3.98	5.30	1.33	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	3702.00	18.71	14.55	12.47	14.55	10.39	8.31	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	1087.16	1.37	2.28	2.51	1.37	1.60	0.46	0.46	0.91
Macrophage - monocyte derived, donor2	11313-117C8	2119.88	4.04	4.77	4.04	1.65	3.12	1.47	0.55	0.37
Macrophage - monocyte derived, donor3	11389-118C3	1970.67	5.51	4.06	3.93	2.49	3.41	2.23	0.92	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2244.63	2.66	0.53	2.66	4.25	2.12	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	3766.88	9.82	4.60	4.60	3.49	2.69	1.58	0.79	0.95
Mallassez-derived cells, donor3	11930-125I4	3773.37	10.56	5.14	3.34	2.08	2.78	1.25	0.83	0.97
Mammary Epithelial Cell, donor1	11273-116H4	2071.89	4.78	1.89	2.49	2.29	1.49	0.90	0.60	0.40
Mammary Epithelial Cell, donor2	11350-117G9	2537.32	3.47	2.61	2.61	1.16	1.74	1.45	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	3818.47	13.72	6.49	8.48	3.49	5.24	1.75	1.00	1.00
Mast cell - stimulated, donor1	11487-119E2	1653.49	6.78	7.46	4.07	6.78	6.78	1.36	0.68	0.00
Mast cell, donor1	11563-120D6	1085.52	1.95	2.05	0.65	3.14	1.41	0.76	0.43	0.00
Mast cell, donor2	11565-120D8	369.98	0.89	1.78	0.59	3.27	1.49	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	293.79	0.00	0.90	1.35	3.83	0.45	0.23	0.00	0.00
Mast cell, donor4	11567-120E1	317.35	1.24	3.19	0.18	3.55	2.13	0.53	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	4134.75	9.20	5.77	3.44	3.99	3.99	2.33	1.44	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	2679.10	4.09	11.67	2.33	4.09	2.92	2.33	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	1569.63	4.93	6.88	4.59	5.51	2.75	1.72	0.80	0.34
Mast cell, expanded, donor8	11941-126A6	1166.05	3.01	9.04	2.85	5.86	3.18	1.84	0.67	0.17
Melanocyte - dark, donor1	11502-119F8	537.39	0.99	0.60	0.60	0.10	0.50	0.60	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	1383.64	5.54	3.46	2.08	0.69	1.38	1.73	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	1052.85	1.59	1.52	0.58	1.16	0.29	0.36	0.22	0.00
Melanocyte - light, donor1	11274-116H5	1269.15	1.65	7.05	1.88	7.05	0.71	1.88	0.71	0.00
Melanocyte - light, donor2	11351-117H1	1501.42	1.36	6.14	4.78	3.41	2.05	1.36	1.36	0.68
Melanocyte - light, donor3	11423-118G1	1261.81	3.47	3.47	4.34	2.60	3.47	3.47	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	1065.93	3.64	4.06	2.71	1.98	1.04	1.15	0.94	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	1172.86	4.30	3.23	2.42	1.08	1.34	0.27	0.54	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	773.03	1.61	4.02	1.61	2.41	0.27	0.80	0.54	0.27
Meningeal Cells, donor1	11493-119E8	2422.39	1.98	1.49	2.36	1.36	1.49	0.62	0.25	0.37
Meningeal Cells, donor2	11573-120E7	1768.51	3.96	1.32	3.52	0.88	0.88	1.32	0.00	0.44
Meningeal Cells, donor3	11654-122E7	2215.70	4.40	3.26	1.55	1.79	1.30	1.30	0.82	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1266.66	5.13	1.71	3.14	0.86	1.43	1.14	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	1523.37	3.52	1.81	1.61	1.91	0.91	0.20	0.70	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	760.90	1.31	1.31	1.31	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2011.95	5.23	3.92	5.23	3.92	1.31	1.31	1.31	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1151.76	9.33	3.59	0.00	5.02	0.00	3.59	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	1193.10	2.12	1.27	2.33	1.69	0.85	1.06	0.64	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	2159.87	7.04	7.04	4.02	8.54	2.01	2.51	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2150.28	2.86	1.76	1.98	1.54	1.10	0.88	0.44	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2041.26	2.19	2.19	3.65	0.00	0.73	2.92	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2294.62	7.77	2.66	2.86	1.84	1.84	1.43	0.82	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	1479.26	2.77	1.66	0.97	0.97	1.80	0.69	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	698.10	1.86	1.49	1.12	1.12	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	1026.02	3.29	1.97	0.92	1.58	0.53	0.66	0.53	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	337.10	1.48	0.59	0.30	0.00	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	558.20	0.00	2.34	0.00	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1959.63	7.04	1.28	3.84	0.64	1.92	2.56	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	1323.50	2.13	1.06	0.71	2.13	2.48	0.71	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	763.98	1.56	0.94	0.94	1.25	0.94	1.56	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	1157.48	4.35	2.18	0.73	1.45	1.45	0.00	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	1959.38	6.36	6.10	3.98	5.04	1.33	2.39	0.80	0.80
Mesothelial Cells, donor2	12156-128G5	1551.45	8.01	3.50	5.00	1.50	2.00	0.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	1428.38	7.59	4.77	2.17	4.05	1.52	1.66	0.72	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	837.20	0.00	0.00	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1726.14	6.40	1.72	1.97	2.71	2.22	1.97	0.49	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	1954.62	5.01	4.12	3.53	4.12	2.06	2.06	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	909.21	0.00	6.91	0.00	3.46	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1300.23	5.89	3.41	1.86	2.17	1.24	2.17	0.93	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	1558.03	5.39	2.28	2.49	1.87	2.28	1.45	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	729.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1546.12	8.26	4.50	2.00	1.00	2.00	1.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	1813.98	1.40	2.33	2.33	2.79	0.47	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	1615.69	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1276.80	4.67	2.03	3.45	1.42	2.64	1.42	0.61	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1656.31	3.17	2.38	4.75	5.54	2.77	3.17	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	1163.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1265.46	5.31	2.65	1.77	1.77	2.65	0.88	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1928.56	9.50	1.90	4.18	4.94	2.28	1.14	1.52	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1072.46	0.00	0.00	0.00	1.32	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1179.33	10.40	3.18	1.27	1.06	1.49	1.06	0.21	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1532.25	0.92	1.84	0.92	2.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	646.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	904.90	4.17	4.17	2.09	2.38	2.68	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1332.96	0.00	3.35	0.00	3.35	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	814.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1243.98	5.77	2.76	3.51	1.76	2.26	1.25	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1429.81	4.52	1.66	3.33	0.71	2.38	1.43	0.24	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1530.93	0.55	1.66	1.66	2.21	1.11	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1442.49	8.52	2.30	1.84	1.38	1.38	1.84	1.15	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1593.32	2.94	3.16	3.16	0.84	1.68	1.26	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1468.18	5.50	1.63	2.04	1.22	0.41	1.02	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1183.18	3.00	1.93	2.36	2.57	1.72	1.29	0.86	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1389.10	0.89	2.22	1.56	2.89	1.56	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	515.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1126.40	3.72	2.19	2.41	1.75	0.88	1.31	0.44	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1234.95	1.01	1.52	0.51	3.55	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	967.69	3.31	3.31	3.31	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1044.77	7.61	1.63	2.17	2.17	0.54	0.27	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1485.41	2.06	1.18	1.47	3.23	0.88	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1413.06	3.27	5.45	3.27	7.63	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1318.64	5.77	2.40	1.44	0.48	1.92	1.44	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1792.23	8.00	6.80	7.20	3.20	2.80	0.80	1.20	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1726.36	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1457.18	6.51	2.50	2.50	2.00	3.00	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	3853.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	1612.45	0.00	0.00	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1516.96	3.94	1.75	2.19	1.31	1.75	2.19	0.00	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1502.07	2.21	1.10	1.10	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1832.79	0.64	0.00	0.00	0.64	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1929.06	7.93	4.96	1.98	1.74	2.23	0.50	0.99	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1320.12	0.70	0.70	0.00	2.78	0.00	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2181.14	0.00	2.21	0.00	6.63	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2200.66	11.97	1.71	3.42	4.10	3.08	2.05	1.71	3.08
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1620.92	0.88	1.31	2.63	2.19	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1971.49	0.00	1.78	0.71	3.55	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2247.50	14.03	6.73	5.61	3.93	2.24	3.09	1.68	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2035.33	1.66	0.83	1.25	6.23	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2214.44	0.58	1.75	1.17	5.24	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1811.80	9.95	3.92	3.02	2.71	2.71	2.41	1.81	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2383.30	7.93	1.67	4.59	4.59	3.34	1.67	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	2634.87	0.00	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1938.54	5.54	2.77	6.46	6.46	5.54	1.85	0.92	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2505.26	3.98	2.85	3.98	2.85	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2079.49	2.49	2.35	2.63	4.15	1.52	0.55	0.41	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2024.99	13.22	5.18	2.33	4.15	2.85	1.81	1.30	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2367.52	0.86	1.72	2.57	3.86	1.72	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2206.02	0.00	1.27	0.00	4.45	1.27	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1394.50	4.00	2.94	1.07	1.33	1.60	0.80	0.80	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2727.79	8.68	3.59	4.19	3.89	2.10	0.90	1.80	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1855.37	1.84	2.12	2.12	2.68	0.99	0.71	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2240.42	8.60	4.14	3.19	2.87	3.50	2.23	1.59	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2466.49	1.99	2.43	1.99	1.55	2.43	0.44	0.88	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2425.74	1.52	2.28	1.14	4.55	1.14	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2182.22	4.83	2.84	2.84	2.84	0.85	2.27	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	3067.38	11.31	4.18	6.64	3.44	3.93	2.21	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2365.56	0.00	1.30	0.65	2.61	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2039.08	7.94	4.70	3.53	3.82	2.06	1.18	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	2962.26	7.78	3.46	4.04	3.17	2.88	2.59	0.86	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2026.51	2.47	2.47	3.71	2.89	1.65	1.65	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2090.44	7.74	2.38	2.08	2.98	1.19	1.79	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1408.81	15.07	15.07	3.77	11.30	3.77	0.00	0.00	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1142.42	3.56	7.13	1.78	1.78	0.00	1.78	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1841.97	11.17	4.93	1.64	2.96	1.31	1.97	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1854.59	10.52	4.21	3.16	2.10	1.05	3.16	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1057.62	2.17	1.98	1.38	0.99	1.78	0.79	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1408.16	0.93	0.93	2.79	2.79	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1040.97	7.14	4.51	3.00	1.50	0.75	1.50	1.13	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1810.33	7.46	3.46	2.13	3.20	1.33	1.07	1.60	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1303.72	2.60	1.24	1.58	0.68	0.68	0.45	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1288.53	11.05	3.68	2.95	1.47	0.00	2.21	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1463.50	6.23	3.30	2.93	4.40	2.20	2.20	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1611.60	15.56	14.00	12.44	14.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	593.23	0.53	0.53	0.53	1.07	0.00	0.53	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	1105.08	3.86	3.86	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1648.22	8.08	4.04	4.04	3.03	6.06	3.03	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1202.94	3.37	1.69	1.69	0.84	0.00	0.00	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	177.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	139.24	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	104.47	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	190.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	411.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	518.73	0.00	0.00	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1140.59	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	564.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	1728.66	3.88	1.51	0.86	1.29	0.86	1.72	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1133.02	1.05	1.05	1.57	0.52	1.57	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3451.58	2.00	4.67	2.67	3.34	2.00	3.34	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	1859.39	0.42	3.76	1.67	4.59	1.67	2.09	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	1439.94	4.94	6.65	4.94	2.09	1.33	2.47	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	3290.65	0.00	1.60	3.19	4.79	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2725.90	0.68	8.16	2.72	4.08	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1508.70	20.21	7.35	12.86	5.51	5.51	3.68	7.35	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2542.60	2.51	4.60	5.02	4.19	2.09	3.35	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	2774.39	4.42	5.58	2.79	4.65	0.93	2.09	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	1877.27	1.62	4.05	2.97	2.70	1.08	1.35	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	2100.69	2.31	1.26	1.26	2.10	1.26	0.21	0.21	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	4854.74	89.08	22.27	66.81	0.00	44.54	0.00	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3144.42	5.46	5.96	17.37	5.96	4.47	5.96	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	923.80	8.12	2.71	2.98	2.71	0.81	1.62	0.81	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2664.65	6.12	9.07	5.21	6.57	2.72	3.40	1.81	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	1494.21	1.47	2.61	2.45	2.45	0.49	1.63	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	1531.31	2.92	1.28	2.19	2.55	1.28	1.28	0.55	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	2118.56	4.24	3.18	7.96	4.77	1.59	2.65	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2071.65	0.60	7.20	9.00	6.00	3.60	1.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	823.07	3.61	4.59	4.92	2.30	0.66	1.64	0.98	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	2100.45	2.11	5.69	3.90	3.42	1.46	1.79	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1170.12	1.06	1.23	1.41	1.76	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1461.32	3.52	3.52	4.22	3.52	3.52	1.41	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1392.46	3.22	3.22	2.30	3.22	1.38	2.30	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1920.36	2.57	6.11	3.53	2.89	1.93	1.93	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	745.30	12.07	12.76	6.21	5.86	1.38	2.41	1.72	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	884.96	10.11	5.06	12.64	10.11	7.59	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	1182.98	0.67	2.23	0.89	2.01	0.22	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	1053.40	1.69	3.39	2.96	2.12	0.85	1.69	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	1104.40	1.42	2.85	2.37	1.90	0.71	0.47	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	2084.86	2.15	3.43	4.72	3.00	0.86	1.72	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	4008.33	126.39	63.19	9.03	0.00	18.06	9.03	18.06	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	1577.14	3.00	2.33	3.33	3.33	2.00	1.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	1209.66	0.90	1.35	0.45	1.80	1.35	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	1827.26	2.38	3.57	2.38	2.38	3.17	0.79	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2962.38	2.79	2.79	13.93	4.64	4.64	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	1105.23	3.78	3.41	2.65	2.65	0.76	1.14	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2101.31	1.96	6.84	1.96	5.21	0.98	2.28	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1253.75	0.44	2.18	2.61	3.05	0.44	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	1003.17	0.00	1.81	0.90	0.90	0.00	1.36	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	1978.12	0.88	2.65	0.00	2.65	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	2010.49	2.66	3.32	5.32	3.32	2.66	2.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2316.03	2.98	5.95	5.95	4.96	2.98	4.46	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	1710.85	0.77	3.83	2.30	4.21	0.38	2.68	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	1077.01	4.23	5.14	4.84	2.72	1.21	1.81	2.12	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1516.22	2.43	1.55	1.55	1.99	0.66	1.55	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1487.45	0.68	3.39	4.07	3.39	1.36	2.03	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1139.43	20.44	0.00	10.22	0.00	0.00	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1935.74	1.22	4.27	5.49	3.66	1.83	2.44	1.22	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	1366.90	0.63	3.15	0.63	2.83	0.31	1.26	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	1188.21	1.21	3.63	1.51	4.54	0.00	0.61	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	1617.09	3.96	7.91	5.54	0.79	4.75	2.37	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	365.03	6.80	5.67	1.13	2.27	0.00	4.53	5.67	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1208.84	10.12	15.17	20.23	5.06	30.35	0.00	15.17	10.12
Myoblast, donor1	11241-116D8	1680.19	6.58	4.22	6.09	3.85	4.10	1.74	1.74	0.62
Myoblast, donor2	11322-117D8	2719.37	15.73	10.16	11.51	5.18	7.48	4.99	3.07	1.53
Myoblast, donor3	11398-118D3	2164.42	3.53	4.04	4.37	2.19	3.20	1.18	0.34	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	1624.09	4.38	2.33	2.48	1.46	2.92	1.75	0.29	0.29
Natural Killer Cells, donor1	11230-116C6	225.41	0.31	0.62	0.31	0.62	0.00	0.31	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	240.64	0.90	0.90	0.90	0.30	0.30	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	254.55	1.66	0.55	0.00	0.37	0.00	0.00	0.55	0.00
Neural stem cells, donor1	11275-116H6	1404.58	4.36	2.90	1.45	2.90	1.09	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	887.72	0.00	1.93	0.00	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	753.29	3.41	0.00	0.00	3.41	2.28	1.14	2.28	0.00
Neurons, donor2	11574-120E8	612.27	0.66	0.66	1.10	0.88	0.66	0.44	0.00	0.00
Neurons, donor3	11655-122E8	603.47	1.64	2.47	1.64	0.82	1.64	3.29	0.00	0.82
Neutrophils, donor1	11233-116C9	141.98	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	144.94	0.00	2.90	0.00	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	353.68	0.00	1.22	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	771.78	2.02	2.26	0.71	0.83	0.71	0.95	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	1099.24	9.12	3.26	1.63	1.63	2.60	0.65	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	1229.19	3.01	2.61	1.80	1.40	1.20	1.60	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	1595.52	3.99	7.02	4.54	3.85	2.06	2.75	1.24	0.41
Olfactory epithelial cells, donor2	11934-125I8	2192.02	16.65	14.19	3.91	7.67	5.21	6.22	2.75	2.17
Olfactory epithelial cells, donor3	11935-125I9	1525.39	4.77	4.43	3.06	2.95	2.50	1.02	0.34	0.45
Olfactory epithelial cells, donor4	11936-126A1	2018.95	3.41	3.70	2.63	2.24	1.75	2.05	0.58	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	1153.69	4.21	0.60	2.41	0.60	0.60	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	1950.83	2.13	3.83	5.53	2.13	2.34	0.85	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	885.91	6.86	3.43	3.43	13.72	0.00	2.29	5.72	1.14
Osteoblast - differentiated, donor3	11425-118G3	545.60	2.48	2.48	2.48	1.24	0.62	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	3137.94	6.84	3.91	7.82	1.95	4.10	0.59	0.78	0.39
Osteoblast, donor2	11354-117H4	2213.00	2.11	0.70	0.70	2.11	2.81	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	2918.15	8.71	3.38	4.44	3.38	5.15	1.78	1.78	1.07
Pancreatic stromal cells, donor1	11249-116E7	1701.89	6.82	5.73	5.05	4.38	2.36	1.94	0.93	0.25
Pericytes, donor1	11491-119E6	1206.35	2.56	1.45	0.67	0.67	0.89	0.67	0.11	0.22
Pericytes, donor2	11571-120E5	929.91	3.40	1.81	1.13	1.13	0.68	0.68	0.00	0.68
Pericytes, donor3	11652-122E5	3361.60	8.75	6.31	7.73	6.31	4.27	2.85	3.46	1.42
Perineurial Cells, donor1	11499-119F5	1858.07	4.18	1.92	1.70	0.79	0.90	1.02	0.34	0.34
Perineurial Cells, donor2	11579-120F4	1274.72	2.21	1.47	1.10	1.38	1.01	0.64	0.46	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	539.31	0.32	0.32	0.32	0.64	0.00	0.64	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	505.40	1.71	1.96	0.98	0.98	0.98	0.00	0.98	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	423.58	0.91	0.91	0.13	0.78	0.78	0.39	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	1750.22	2.15	4.30	1.67	1.67	1.67	0.96	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	1658.89	7.76	8.87	0.00	6.65	0.00	3.33	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	1508.77	6.48	6.48	1.57	4.12	3.14	1.96	0.39	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	786.07	5.06	7.91	3.80	4.11	3.48	2.22	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	1131.34	1.88	2.06	2.81	2.81	0.56	0.94	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2240.76	3.92	2.87	2.87	2.22	2.48	1.17	0.65	0.52
Preadipocyte - breast, donor2	11328-117E5	1086.12	8.56	3.83	4.28	1.80	3.60	0.90	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	1334.33	3.84	2.02	4.48	2.88	2.34	0.85	0.43	0.32
Preadipocyte - omental, donor2	11329-117E6	1029.20	2.62	3.93	2.62	2.18	3.06	1.31	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	1212.46	4.44	2.44	3.29	3.29	1.86	1.86	0.72	0.29
Preadipocyte - perirenal, donor1	11469-119C2	1562.03	7.87	2.95	8.86	0.98	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2517.13	2.15	3.07	3.07	2.15	2.46	0.61	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	2059.94	16.47	10.27	1.77	2.48	2.48	1.24	0.89	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	1841.46	9.20	11.24	2.21	6.13	2.21	2.38	1.36	1.19
Preadipocyte - visceral, donor1	11280-116I2	2055.95	2.79	5.50	1.30	3.82	1.02	0.65	0.28	0.00
Preadipocyte - visceral, donor2	11357-117H7	2456.90	13.35	9.20	3.22	8.74	1.84	2.76	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	1523.47	7.31	4.81	1.99	3.55	2.61	1.67	0.63	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	540.35	2.26	3.92	2.26	2.87	0.75	1.06	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	2909.90	20.85	26.54	11.24	12.32	7.99	4.60	2.57	1.49
Prostate Epithelial Cells, donor3	11404-118D9	448.87	2.45	2.57	1.41	1.78	0.92	0.24	0.37	0.00
Prostate Stromal Cells, donor1	11254-116F3	2361.04	9.57	5.35	6.72	4.33	4.21	1.94	0.57	0.80
Prostate Stromal Cells, donor2	11332-117E9	2522.73	19.01	6.99	7.53	5.20	6.45	3.23	1.79	1.43
Prostate Stromal Cells, donor3	11405-118E1	1397.61	11.57	12.83	4.38	5.94	2.82	2.71	1.46	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	2111.06	3.28	1.09	1.82	1.46	0.36	0.00	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	2149.50	4.99	3.53	1.18	2.08	1.66	1.18	0.76	0.14
Renal Epithelial Cells, donor1	11517-119H5	3402.00	5.07	4.06	3.55	2.54	3.55	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3582.21	8.54	4.27	7.11	2.13	2.85	0.00	2.13	0.71
Renal Epithelial Cells, donor3	11678-122H4	2274.40	5.40	2.75	1.16	2.01	1.91	1.06	0.74	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1452.94	5.45	4.09	3.40	2.72	0.68	1.36	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1523.24	3.91	1.89	5.12	1.48	1.35	1.08	0.13	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1799.18	7.33	3.11	1.78	2.89	2.22	2.22	1.11	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	685.41	2.00	2.66	1.33	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3254.44	4.62	4.40	2.64	2.42	0.66	1.32	0.44	0.88
Renal Mesangial Cells, donor2	11598-120H5	2958.11	9.40	3.13	6.90	2.51	2.51	2.51	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	2508.63	5.27	4.99	6.66	2.50	1.94	2.22	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	3545.06	4.29	2.15	2.68	1.07	2.95	1.34	0.54	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2350.94	5.06	3.37	3.37	3.80	2.11	1.69	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3618.20	11.76	6.36	6.94	5.21	4.82	2.51	2.89	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2137.52	5.96	2.85	2.07	2.33	2.33	1.30	0.52	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	976.95	1.42	2.27	1.71	0.28	0.57	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2448.28	5.15	6.17	6.17	2.06	2.06	2.06	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	1018.68	2.01	1.51	0.75	1.51	0.25	0.50	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	265.67	0.27	0.53	0.80	0.40	0.40	0.13	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	348.43	0.00	0.00	0.00	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	348.38	0.55	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	245.36	0.00	0.00	0.00	0.58	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	552.48	1.56	0.26	1.17	0.65	0.52	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	585.80	2.09	1.49	0.60	1.09	0.89	0.79	0.10	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	649.83	1.45	0.67	0.11	0.33	0.89	0.22	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	712.63	3.23	0.50	2.23	0.62	1.61	0.50	0.37	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	628.99	3.96	2.68	0.82	1.63	0.82	1.28	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	597.24	2.08	1.85	1.39	0.92	0.69	0.46	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	644.98	0.82	0.27	0.68	0.68	0.41	0.68	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	511.45	4.54	1.66	1.97	0.91	1.21	0.76	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	477.36	0.72	1.08	0.54	0.18	0.00	0.00	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	656.31	1.72	0.14	0.57	1.15	0.72	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	639.49	3.00	1.93	0.86	1.29	0.43	0.54	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	552.73	1.99	1.55	0.66	1.77	0.66	0.89	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	699.71	0.96	0.57	1.15	0.57	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	572.77	1.12	0.93	1.21	0.75	0.56	0.28	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	689.62	0.56	0.56	0.75	0.19	0.00	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	642.83	0.80	0.27	0.40	0.93	0.00	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	501.50	2.73	1.75	0.39	0.49	0.97	0.49	0.39	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	558.75	1.91	2.10	0.57	0.19	0.57	0.57	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	622.50	0.64	0.32	0.53	1.17	0.21	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	542.67	3.92	1.68	2.24	2.52	1.40	0.28	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	519.36	1.71	1.71	1.20	0.51	0.17	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	661.13	0.73	0.36	0.55	0.91	0.18	0.18	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	532.10	3.07	1.72	0.49	0.86	1.10	0.86	0.25	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	573.14	2.69	2.01	0.54	0.54	0.40	0.13	0.94	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	839.00	0.94	0.00	1.18	0.94	0.24	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	581.35	2.98	1.19	1.19	0.79	0.40	0.40	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	601.45	1.40	1.40	1.40	0.47	1.17	0.94	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	708.53	1.66	0.83	2.07	0.62	0.21	0.41	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	788.39	3.32	1.99	1.77	1.77	1.33	1.11	0.44	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	511.35	1.25	1.67	0.21	1.25	0.42	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	689.48	0.40	0.27	0.27	1.48	0.27	0.54	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	547.67	1.02	0.17	0.34	0.34	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	457.31	1.93	1.74	0.39	0.77	0.39	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	710.79	0.86	0.34	0.34	0.00	1.20	0.86	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	517.95	0.69	0.69	0.27	1.23	0.14	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	514.34	3.28	1.15	0.33	0.66	1.15	0.49	0.16	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	593.95	0.00	0.68	0.17	0.34	0.51	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	443.87	2.52	1.48	0.15	0.89	0.15	0.74	0.30	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	464.86	0.80	0.53	0.80	0.80	0.27	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	338.20	0.14	0.28	0.69	0.14	0.28	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	481.44	0.95	0.48	0.95	0.95	1.19	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	569.35	0.40	0.40	0.81	0.81	0.20	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	564.95	2.26	1.41	1.13	0.57	0.19	0.28	0.19	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	322.81	1.05	0.70	0.00	0.70	0.35	0.70	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	204.30	0.00	0.00	0.91	0.00	0.60	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	733.95	1.35	1.47	0.98	2.45	0.86	0.61	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	294.74	0.15	0.58	0.15	0.15	0.44	0.29	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	408.86	1.83	1.83	1.22	0.61	1.22	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	769.47	1.51	0.90	0.90	0.60	0.60	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	362.35	0.90	2.04	0.90	2.71	0.68	0.00	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	404.68	0.90	0.60	0.60	1.50	0.60	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	287.87	1.30	1.30	0.94	1.65	0.35	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	349.20	0.64	1.28	1.28	2.13	1.28	0.21	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	381.02	0.60	0.60	1.20	0.60	0.00	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	2531.62	7.52	5.08	3.95	3.01	2.82	1.13	0.56	0.56
Schwann Cells, donor2	11578-120F3	1816.89	13.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	1392.70	9.64	4.38	1.53	3.29	2.19	2.19	1.53	0.88
Sebocyte, donor1	11220-116B5	2387.18	0.55	3.29	2.19	8.22	1.10	1.64	1.10	0.00
Sebocyte, donor2	11301-117B5	1959.54	8.73	9.19	5.97	5.51	2.76	1.38	3.22	1.38
Sebocyte, donor3	11378-118B1	1439.90	3.50	8.24	3.09	5.57	0.82	1.24	0.41	0.00
Sertoli Cells, donor1	11255-116F4	3010.04	8.28	16.57	4.97	6.63	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2962.76	33.89	14.12	14.12	5.65	16.95	8.47	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	1660.14	2.29	4.57	1.76	7.74	2.02	1.14	0.26	0.26
Skeletal Muscle Cells, donor2	11358-117H8	955.60	5.78	3.61	5.78	2.17	2.89	2.89	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	4767.09	19.23	8.36	14.21	7.52	5.02	1.67	0.84	7.52
Skeletal Muscle Cells, donor4	11451-119A2	1559.31	3.77	2.20	4.71	1.41	2.83	0.79	0.47	0.94
Skeletal Muscle Cells, donor5	11455-119A6	1485.70	5.35	2.38	5.35	2.38	3.86	0.59	0.15	1.04
Skeletal Muscle Cells, donor6	11459-119B1	1690.31	4.92	3.08	4.00	2.15	2.46	0.46	0.15	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	1057.70	3.02	1.51	1.64	1.26	1.13	0.76	0.13	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	1045.19	5.14	3.28	2.57	1.00	1.85	1.14	0.71	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	1716.13	6.35	3.67	5.26	1.39	2.78	2.08	1.79	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	1687.23	2.44	1.85	0.59	2.78	0.67	0.84	0.08	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3306.88	11.58	7.24	11.58	2.90	2.17	3.62	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2661.58	11.83	4.95	9.22	2.75	8.12	1.79	0.69	2.48
Skin - palm, donor1	10286-104F7	789.72	5.37	0.00	0.00	0.00	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1692.68	5.91	9.51	7.35	7.50	2.31	3.17	0.43	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	4624.36	4.09	5.73	1.64	5.73	2.45	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2061.27	5.45	9.22	6.36	6.75	4.93	2.47	1.43	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	1843.25	4.73	5.42	6.95	5.56	4.03	1.67	1.11	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	1412.20	3.38	4.22	4.64	2.67	2.67	2.11	0.14	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	2157.80	3.59	3.59	3.81	1.90	1.90	1.90	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	800.55	2.55	2.62	2.92	2.77	2.10	0.67	0.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	2925.99	8.33	8.02	3.70	6.17	1.85	3.39	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3807.42	5.56	4.22	2.67	4.22	2.45	1.78	0.67	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	1885.75	2.94	1.18	1.18	1.18	1.76	0.59	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	2191.79	2.43	4.20	2.65	1.77	1.33	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3027.38	3.54	3.94	1.97	3.54	2.36	0.39	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	2441.31	2.32	0.77	2.32	0.77	0.00	0.77	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	351.27	2.00	2.00	0.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3011.41	5.46	6.39	4.26	4.92	4.26	1.20	0.53	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	1600.12	13.74	3.99	1.33	4.88	2.88	1.55	1.11	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1694.23	6.15	1.92	2.69	2.82	4.10	1.15	0.64	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	781.09	1.63	0.98	0.98	0.65	1.30	0.98	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	1026.26	2.66	2.36	1.18	1.18	0.59	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	975.34	3.56	2.28	2.14	1.14	1.57	1.42	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1987.07	4.39	0.49	1.46	0.33	0.98	0.65	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	585.42	1.83	0.00	0.30	1.22	0.30	0.91	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3903.11	4.04	10.61	5.30	5.30	3.28	1.26	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	2613.54	0.00	0.00	0.00	30.60	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3195.76	15.74	8.58	6.68	7.63	4.29	2.38	0.48	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	1199.41	2.51	1.47	2.06	1.47	1.33	1.18	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	1320.92	5.17	5.38	2.80	2.15	3.44	0.86	1.51	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	1437.72	4.41	3.57	4.20	1.99	4.30	1.15	1.15	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2861.09	3.25	3.71	4.64	3.71	2.78	0.93	0.77	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3700.35	12.93	5.39	5.39	8.62	7.55	8.62	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2121.58	5.98	2.69	5.38	2.69	4.18	0.90	0.60	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1899.20	1.71	2.05	2.39	2.05	1.02	2.05	0.68	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1251.28	3.38	1.81	1.26	0.79	0.86	0.47	0.31	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	2879.85	7.95	28.18	6.64	38.95	3.42	2.31	1.21	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	2204.76	12.06	7.74	2.73	5.92	2.73	2.05	0.91	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3893.37	9.06	12.68	8.45	5.43	10.26	3.62	1.21	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	1656.84	2.12	1.59	1.85	0.79	1.59	2.12	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1749.31	3.20	2.93	1.60	3.20	1.60	0.53	0.27	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	1672.56	11.02	8.89	3.88	6.01	2.63	2.63	0.38	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	697.32	1.27	1.52	0.76	2.03	2.03	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	2817.50	3.77	3.47	3.62	4.07	3.47	1.36	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3050.93	14.25	10.50	6.75	1.50	1.50	2.25	3.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1071.25	5.17	11.63	20.68	6.46	0.00	5.17	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2903.43	1.40	6.05	3.26	3.72	6.98	0.47	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2723.84	9.59	6.06	4.54	5.55	3.53	1.51	1.01	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3234.54	16.92	8.78	9.40	3.45	9.72	3.76	0.00	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1469.10	3.54	2.06	3.54	1.77	1.18	2.06	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1096.90	0.58	0.50	0.33	0.83	0.50	0.17	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	651.22	2.34	1.40	0.93	0.93	1.40	0.93	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	3086.47	3.17	3.02	3.45	3.02	2.30	1.30	0.29	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3084.71	11.73	8.92	9.18	4.33	6.37	2.55	1.53	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3486.89	9.97	3.38	10.34	3.01	6.21	3.57	0.56	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1498.20	4.33	0.70	0.98	1.26	2.24	1.40	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	1031.68	1.17	0.92	0.92	0.84	0.42	0.17	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	681.89	1.43	1.90	1.43	0.48	0.95	0.00	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2731.89	5.63	3.91	4.89	4.16	4.16	1.22	0.98	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1873.42	3.09	3.54	3.98	4.42	1.99	1.55	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1250.19	2.93	3.80	2.63	2.05	2.63	0.88	0.29	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	764.42	1.36	1.36	0.97	1.55	0.39	0.19	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2459.15	7.93	3.44	4.50	6.61	3.17	3.17	3.17	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1586.35	7.07	2.98	3.72	5.95	3.72	1.12	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	2370.55	6.11	4.31	4.67	6.47	1.44	3.23	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3158.67	5.39	3.69	4.54	5.96	2.27	0.85	1.14	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	2392.36	7.09	2.76	1.58	5.51	1.58	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	1388.86	7.36	5.33	2.54	5.08	4.32	2.03	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	1084.55	2.00	2.40	1.60	2.40	1.60	0.80	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	1070.09	5.43	4.60	1.25	2.09	0.42	1.67	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	677.00	2.29	0.92	0.92	1.38	0.00	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	1912.97	2.52	5.05	2.36	6.90	1.51	0.67	0.50	0.34
Synoviocyte, donor2	11368-117I9	979.09	5.53	5.87	2.51	4.36	1.84	1.51	0.50	0.50
Synoviocyte, donor3	11440-118H9	959.10	5.59	3.57	1.34	2.90	1.56	0.67	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	2693.56	2.50	1.79	0.71	2.86	1.07	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	2138.62	3.96	7.93	1.98	0.00	0.00	0.00	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	1694.92	3.70	2.32	1.16	2.32	2.55	1.62	0.46	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	2032.68	3.37	2.08	1.79	1.72	2.37	0.57	0.22	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	2850.90	11.60	5.80	6.19	3.87	3.87	1.55	1.16	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	3010.49	12.03	3.44	8.02	4.58	6.87	2.86	1.72	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	259.83	1.23	0.98	0.74	0.74	0.74	0.37	0.12	0.00
Urethra, donor2	10319-105A4	607.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2903.15	5.05	3.19	3.98	1.86	2.13	1.86	0.80	0.53
Urothelial Cells, donor2	11600-120H7	2441.84	6.81	6.01	4.01	3.20	4.41	0.80	1.20	0.80
Urothelial Cells, donor3	11681-122H7	2484.58	8.25	4.58	3.90	2.98	2.98	2.29	0.69	1.15
Urothelial cells, donor0	11216-116B1	1591.03	4.46	4.24	0.67	1.56	0.89	1.34	0.89	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	1144.26	0.89	0.89	4.45	0.89	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1082.22	1.43	0.00	1.43	1.43	0.00	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	674.94	4.79	2.05	0.68	0.68	0.00	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	604.31	3.44	0.69	0.34	0.34	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	690.84	2.91	1.16	0.58	1.74	1.16	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	971.48	1.04	0.00	3.12	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	867.31	0.92	0.00	0.92	0.00	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	725.75	5.48	2.74	1.83	0.91	3.65	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	1083.48	4.44	2.71	2.10	1.60	1.48	0.86	0.12	0.12
Wilms' tumor cell line:HFWT	10597-108E3	1181.89	0.88	0.88	0.88	1.76	0.88	1.76	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	732.09	1.96	1.96	1.96	0.28	1.40	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	822.48	4.13	2.07	2.07	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1348.21	5.86	2.55	3.57	2.55	2.80	1.78	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1322.70	1.63	1.63	1.63	1.16	1.86	0.70	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	967.59	2.61	0.83	1.19	0.83	0.95	1.07	0.12	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1763.57	5.17	3.27	1.90	2.72	2.72	0.82	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1170.71	5.34	2.25	3.09	1.41	3.09	1.97	1.41	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	863.69	1.90	0.85	1.48	0.63	1.06	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1824.63	6.26	2.72	2.45	2.72	0.82	1.36	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	842.50	2.20	0.44	0.44	0.88	0.88	1.32	0.44	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	864.50	3.27	2.45	2.04	1.23	0.41	0.82	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	825.91	3.88	0.00	1.94	0.78	1.16	1.16	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1807.25	9.75	4.05	3.31	2.94	1.66	1.47	1.47	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1224.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1129.38	5.58	2.32	3.25	1.16	1.39	0.93	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1232.63	6.21	2.07	2.59	1.04	0.52	0.78	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1125.72	8.77	2.34	2.92	2.34	2.05	2.05	0.88	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1351.06	1.86	0.46	2.32	0.93	0.46	1.39	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	2269.29	8.23	4.94	2.47	3.70	2.88	2.88	2.06	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	367.11	0.31	0.61	0.31	1.23	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	521.01	0.85	2.56	0.85	0.85	1.71	0.00	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	632.67	1.21	1.82	1.21	0.30	0.30	0.61	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	552.66	2.41	0.96	0.48	1.93	0.00	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1894.17	6.01	2.45	4.01	3.56	1.11	1.11	1.56	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	2088.67	2.00	3.67	3.00	5.00	1.00	0.67	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	245.28	0.00	0.00	0.00	0.00	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	445.59	3.01	1.51	1.51	0.75	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	694.32	0.44	2.62	0.87	0.87	2.18	1.31	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	678.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	960.37	1.18	1.88	3.30	1.41	0.71	0.94	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	309.31	0.93	0.78	1.09	0.62	1.24	0.16	0.16	0.00
adipose, donor1	10184-103D4	707.21	12.31	8.80	7.62	4.69	5.86	1.76	0.59	1.76
adipose, donor2	10185-103D5	2038.94	4.06	13.79	4.06	7.70	2.03	2.84	0.00	0.41
adipose, donor3	10186-103D6	1471.72	5.45	9.26	7.35	7.62	3.81	2.18	0.27	0.00
adipose, donor4	10187-103D7	732.41	3.47	11.27	3.47	7.80	0.00	0.00	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	927.03	1.26	0.95	1.26	1.26	0.32	0.63	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	698.43	0.00	0.00	0.00	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	2110.09	2.93	3.20	2.27	2.13	2.27	1.07	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	2648.31	5.00	4.64	5.72	5.36	4.29	3.93	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	1113.34	3.01	1.16	1.85	2.32	1.85	0.93	0.46	1.62
amniotic membrane cells, donor2	12236-129G4	714.75	1.35	2.37	1.69	2.03	1.69	1.35	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	1333.07	2.06	2.36	2.95	2.65	2.06	0.59	0.29	0.29
amygdala - adult, donor10196	10167-103B5	1013.86	0.00	13.04	2.37	0.00	2.37	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	712.12	1.82	5.88	0.41	2.03	0.61	0.41	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	600.35	0.00	3.23	0.32	0.00	0.65	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	2409.72	4.71	3.31	2.42	5.86	2.04	1.02	0.25	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1785.06	5.96	4.85	5.96	4.63	3.09	2.43	0.88	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	860.48	0.67	1.00	0.33	1.00	1.00	0.67	0.67	0.00
aorta, adult, pool1	10052-101G7	477.78	2.35	0.20	0.98	0.59	0.00	0.39	0.78	0.20
appendix, adult	10189-103D9	501.06	1.94	1.94	0.39	0.78	0.39	0.39	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1725.52	4.82	4.82	2.06	4.47	1.38	0.69	0.34	0.69
artery, adult	10190-103E1	2116.84	9.51	16.30	9.51	1.36	4.08	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	2723.07	3.77	3.19	4.35	3.62	2.61	1.16	0.87	0.72
b cell line:RPMI1788	10427-106D4	2057.88	3.57	2.83	1.34	1.49	0.89	1.49	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	2358.58	8.88	8.05	7.49	5.55	8.60	2.77	1.66	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	1331.99	2.28	1.19	2.08	1.49	1.29	0.60	0.30	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	2191.99	3.51	3.68	2.68	4.85	1.67	1.84	0.50	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	233.76	0.00	0.00	0.00	0.00	0.56	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	362.64	0.43	1.52	0.43	0.43	0.43	0.43	0.11	0.22
blood, adult, pool1	10053-101G8	644.46	2.21	0.00	0.00	0.00	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	780.99	0.00	0.86	0.86	5.14	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	1159.35	8.10	4.72	4.05	3.37	2.70	0.67	1.35	2.02
brain, adult, donor1	10084-102B3	926.66	4.10	6.15	2.05	0.00	3.08	2.05	0.00	1.03
brain, adult, pool1	10012-101C3	812.47	1.78	4.01	1.56	1.00	1.56	1.00	0.56	0.11
brain, fetal, pool1	10085-102B4	491.54	2.67	5.34	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	543.78	1.32	1.65	0.66	2.97	0.33	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	877.88	1.37	1.00	0.62	1.37	0.75	0.37	0.00	0.00
breast, adult, donor1	10080-102A8	455.21	0.00	0.63	1.26	0.63	0.63	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2826.21	7.75	4.45	5.72	6.48	3.56	1.78	1.27	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	2206.60	5.26	3.09	4.64	5.57	4.95	0.62	1.24	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	3452.14	11.28	8.98	5.99	4.83	3.45	2.99	2.30	2.07
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	1250.86	3.63	2.18	4.12	1.94	3.39	1.94	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	1472.57	3.29	2.35	2.35	0.94	3.76	1.41	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	1121.81	1.20	2.63	1.53	2.84	1.31	0.98	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	2233.16	4.12	4.75	7.92	3.80	3.80	1.90	0.95	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	617.00	1.60	1.06	1.60	0.53	0.80	0.27	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	1127.15	1.15	2.30	0.00	1.15	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	953.76	2.18	3.01	1.00	0.33	1.34	0.50	0.33	0.67
caudate nucleus, adult, donor10258	10379-105H1	1248.60	0.00	2.29	0.00	0.00	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	1023.62	1.46	1.46	0.73	0.73	1.83	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	1142.00	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	728.28	1.71	1.71	0.85	1.49	1.07	0.00	0.43	0.00
cerebellum, adult, pool1	10083-102B2	737.84	2.07	0.34	1.38	0.34	0.69	1.03	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	1097.64	0.83	0.83	0.00	0.83	0.83	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	1013.60	3.28	7.06	1.76	0.50	1.76	1.51	0.50	0.50
cerebrospinal fluid, donor2	10294-104G6	1675.92	6.58	5.12	4.39	0.73	1.46	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	560.75	1.15	0.14	0.43	1.01	0.14	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	1156.37	1.66	0.83	1.99	1.82	0.33	0.83	0.33	0.17
cervix, adult, pool1	10013-101C4	447.05	1.05	1.36	0.73	2.10	0.94	0.52	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2135.64	4.74	2.79	2.93	2.93	5.02	1.67	0.70	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	1521.79	0.00	1.31	2.61	1.31	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	804.69	1.74	2.73	2.24	5.59	0.87	0.50	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	1010.71	2.59	1.97	1.48	1.60	1.23	0.49	0.25	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	871.39	0.00	2.13	0.71	1.19	0.71	0.71	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	701.76	3.13	0.28	2.56	2.56	1.71	1.42	0.00	1.99
chorionic membrane cells, donor2	12239-129G7	1016.88	4.18	3.58	3.98	2.88	3.28	1.29	0.50	0.50
chorionic membrane cells, donor3	12240-129G8	833.02	13.19	5.49	3.30	4.95	5.49	1.10	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1669.20	17.17	5.05	0.00	4.04	6.06	3.03	1.01	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	1217.14	3.27	1.54	2.50	1.34	1.15	0.38	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	380.56	0.63	1.27	0.84	0.63	0.42	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	714.68	1.80	0.77	0.51	0.26	0.26	0.51	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	839.08	1.21	0.97	0.97	0.97	0.48	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	709.99	2.24	1.22	0.20	1.63	0.20	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	138.10	0.00	0.29	0.00	0.29	0.59	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	886.65	0.52	0.00	1.04	1.56	0.78	0.26	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	2616.35	20.80	10.06	8.91	8.23	7.31	5.49	1.83	1.14
clear cell carcinoma cell line:TEN	10636-108I6	1806.89	7.29	2.95	3.47	1.04	3.64	1.21	1.21	0.52
colon carcinoma cell line:CACO-2	10513-107D9	1006.55	2.20	1.28	1.28	0.73	0.55	0.37	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	566.32	0.38	0.38	0.38	0.38	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	458.16	0.00	0.00	0.00	0.00	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	256.86	0.35	0.71	0.59	1.53	0.71	0.59	0.00	0.00
colon, fetal, donor1	10070-101I7	508.60	1.24	2.47	1.24	0.00	1.24	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	123.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	325.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1316.87	2.97	1.27	0.42	1.70	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2200.73	3.62	2.11	3.32	8.75	1.36	1.66	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	2329.22	4.79	1.69	3.67	2.26	1.69	1.41	0.85	0.14
corpus callosum, adult, pool1	10042-101F6	655.52	0.66	1.22	0.88	0.33	0.55	1.11	0.00	0.00
cruciate ligament, donor2	10295-104G7	769.14	3.24	0.81	0.81	1.62	0.00	1.62	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	1308.98	4.01	0.80	0.80	0.80	1.61	0.80	3.21	0.00
diencephalon, adult	10193-103E4	970.03	5.28	2.40	0.96	0.24	0.96	0.72	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1703.26	14.70	5.97	3.44	3.90	3.90	1.84	1.61	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	737.52	0.26	0.51	0.77	1.54	0.77	0.26	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1687.46	2.41	2.17	3.37	3.85	1.44	0.48	0.24	0.24
ductus deferens, adult	10196-103E7	492.86	3.49	2.49	0.50	1.50	1.00	1.00	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	383.10	0.00	1.44	0.00	1.44	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	533.35	1.47	2.94	0.00	2.21	0.74	0.74	0.74	0.74
dura mater, adult, donor1	10041-101F5	697.53	0.41	1.90	0.25	0.83	1.57	0.41	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	1610.03	3.11	5.77	4.66	11.10	3.78	2.00	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2094.66	4.30	2.72	2.15	2.29	2.87	1.15	0.72	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	1391.70	0.00	0.62	0.62	1.85	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	1163.62	2.12	2.72	0.61	1.82	2.12	0.91	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	1541.28	0.93	1.54	0.93	2.47	0.31	0.62	0.00	0.62
embryonic pancreas cell line:2C6	10603-108E9	1144.03	0.00	1.31	0.00	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	726.37	1.68	1.01	0.67	2.35	1.34	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1098.65	3.44	1.45	1.99	2.36	1.27	0.54	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1747.07	12.54	6.27	3.86	3.54	4.18	2.25	1.45	1.13
epidermoid carcinoma cell line:A431	10426-106D3	1450.62	1.33	2.22	0.67	3.45	1.33	0.78	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	2787.25	4.40	3.52	2.20	2.97	1.76	2.09	0.22	0.33
epididymis, adult	10197-103E8	640.28	2.09	2.72	1.26	1.05	1.26	1.05	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1695.15	3.37	2.66	3.02	3.73	1.06	0.71	0.53	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1401.51	2.36	3.15	1.18	2.36	1.57	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	3393.14	16.64	7.73	4.98	4.46	3.54	3.41	3.67	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	2836.37	11.52	6.00	2.85	3.94	2.26	2.17	1.38	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3212.67	14.68	9.30	5.38	6.16	5.94	4.03	1.79	1.34
esophagus, adult, pool1	10015-101C6	571.45	1.38	2.12	1.17	2.87	1.06	0.64	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	896.44	0.88	1.38	0.75	1.63	0.63	0.00	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	1320.77	14.49	0.00	0.00	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2823.84	6.31	0.00	4.21	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1867.71	5.95	0.00	0.00	0.00	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	1665.86	0.00	2.29	0.00	0.00	0.00	3.44	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	1208.18	4.37	2.91	1.46	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	2105.82	10.93	3.56	2.29	2.29	5.08	2.54	1.78	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	2022.23	3.33	2.95	4.49	3.33	3.21	1.54	1.41	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	2103.77	2.85	3.32	4.04	2.85	3.09	1.66	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	1040.98	1.60	7.32	1.41	0.47	0.84	0.38	0.09	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	803.77	1.50	1.50	1.20	1.80	0.90	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1238.14	2.01	1.46	1.46	2.10	0.55	0.82	0.18	0.00
gall bladder, adult	10198-103E9	373.50	2.90	1.69	0.97	1.21	0.00	0.72	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	281.31	2.15	0.00	0.54	0.00	0.54	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	286.09	1.12	0.75	0.00	0.37	0.37	0.00	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	906.75	5.91	2.96	5.49	4.01	5.07	1.27	0.63	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	1139.41	2.51	1.55	1.93	1.55	1.55	1.35	0.19	0.77
gastric cancer cell line:AZ521	10549-107H9	513.02	0.66	0.49	0.49	0.66	0.66	0.16	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	1128.47	1.83	2.75	0.92	0.92	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	468.34	1.83	1.37	1.14	0.00	0.69	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	1210.74	2.87	1.84	1.38	1.49	0.80	1.03	0.34	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	2504.15	2.66	3.50	1.82	4.20	1.12	1.54	0.14	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	2659.30	5.74	6.98	6.48	10.97	6.48	1.75	1.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	1673.74	2.11	2.74	2.53	4.64	1.69	1.06	0.42	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	1543.70	1.83	2.25	2.25	2.25	2.11	0.84	0.14	0.28
glioblastoma cell line:T98G	10485-107A8	3113.08	5.08	3.53	3.20	5.08	2.98	1.66	0.66	0.55
glioma cell line:GI-1	10413-106B8	933.99	4.39	1.46	0.59	3.51	0.29	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	1215.10	0.00	2.19	0.00	0.00	1.46	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	640.99	1.22	1.95	1.22	0.73	0.24	0.49	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	1229.55	4.11	1.37	4.11	1.37	1.37	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	670.41	0.53	0.00	0.00	1.07	0.53	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	291.21	0.00	0.00	0.00	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	775.91	10.93	10.93	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	554.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	2102.05	5.44	2.56	1.92	2.56	2.24	0.64	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	1320.41	1.38	2.30	0.00	1.38	0.46	1.84	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	1401.97	1.83	0.46	0.46	0.91	1.37	2.29	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	1612.16	1.29	1.93	0.64	1.29	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	1657.19	0.00	1.44	1.44	2.87	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	1393.68	1.37	2.06	0.00	0.69	0.00	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	1526.10	2.21	1.10	1.10	0.00	1.10	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	1847.62	6.03	2.59	5.75	3.45	4.31	1.72	0.57	0.29
heart - mitral valve, adult	10205-103F7	576.41	1.49	1.20	0.90	0.90	1.79	1.20	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	567.92	1.05	1.31	0.26	0.78	0.78	1.05	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	467.94	0.83	0.00	0.00	0.83	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	642.78	2.65	1.02	1.63	0.41	0.82	1.02	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	1143.36	4.26	1.28	2.13	1.70	2.13	0.43	1.28	0.43
heart, adult, pool1	10016-101C7	541.14	0.92	1.61	1.84	0.69	0.92	1.38	0.00	0.00
heart, fetal, pool1	10046-101G1	1160.08	1.64	0.82	1.03	1.13	0.72	0.51	0.21	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1089.40	1.54	1.54	1.23	2.78	0.31	1.54	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	523.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1228.05	6.74	2.10	1.10	1.10	1.55	0.33	0.77	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1190.68	7.40	3.28	1.21	1.58	0.73	0.97	2.06	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1372.00	5.96	2.73	1.01	1.31	1.52	0.91	0.81	0.30
hepatoma cell line:Li-7	10484-107A7	1185.67	2.67	1.56	1.56	1.67	0.67	0.44	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1518.06	3.22	0.80	1.41	1.41	1.31	0.90	0.40	0.40
hippocampus - adult, donor10196	10169-103B7	1053.26	0.95	0.95	0.95	0.95	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	629.85	2.04	2.45	0.41	1.63	0.41	0.82	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	1319.07	0.00	1.00	0.50	0.00	0.00	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	795.89	0.70	2.11	0.35	0.70	0.35	0.00	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	996.08	9.16	3.05	3.66	5.49	3.05	1.22	2.44	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	925.81	2.36	3.73	2.95	2.95	2.16	0.98	0.98	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1038.43	3.30	3.05	2.54	1.52	2.03	1.27	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	883.58	2.26	2.82	2.26	6.20	1.69	1.13	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	775.67	11.88	12.65	8.78	9.55	4.39	2.32	2.07	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	960.79	5.31	7.59	6.45	2.66	2.66	1.52	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1247.81	3.21	7.30	6.71	6.13	3.50	1.75	0.58	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1110.10	5.60	11.42	9.48	15.08	4.74	3.02	1.51	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1116.09	1.67	5.42	4.17	8.34	2.09	0.42	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	1041.89	2.60	2.37	2.37	2.84	2.60	0.71	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1074.88	5.46	7.55	3.54	6.75	4.02	2.25	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	890.11	1.35	2.02	3.37	3.37	3.37	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1406.01	5.95	7.20	6.73	7.51	2.97	2.19	0.78	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1455.70	12.28	7.86	6.39	3.93	8.35	3.44	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1932.28	6.98	8.73	7.85	5.24	2.62	1.75	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1124.27	3.63	7.64	5.92	7.83	3.63	1.53	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1262.87	2.18	4.80	6.98	6.11	0.44	1.31	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1253.40	3.00	9.00	12.49	5.50	3.50	0.50	1.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2022.95	8.85	18.46	14.51	20.72	12.81	4.52	1.13	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2395.91	7.73	19.10	11.82	15.01	6.37	4.55	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	2329.85	4.39	15.66	9.40	13.16	4.70	3.76	1.25	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	2367.39	8.82	15.68	8.98	16.00	7.68	4.57	2.61	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	2389.54	8.13	17.13	11.03	13.06	6.39	1.74	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	2845.15	6.88	13.45	6.58	14.95	6.58	3.59	1.79	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1357.69	7.57	4.43	5.54	7.21	2.22	2.40	0.92	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1246.12	1.71	3.99	3.42	4.28	1.71	2.00	0.57	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1394.38	6.53	6.53	5.72	4.90	3.27	1.22	2.45	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1345.30	9.15	11.97	5.63	5.99	2.82	1.76	1.06	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1191.26	4.12	6.65	5.07	9.19	3.80	2.22	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1449.85	6.66	9.38	5.75	10.29	3.33	1.82	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1927.32	0.52	11.38	4.14	15.51	2.59	1.55	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2035.01	1.99	6.64	1.99	9.30	1.99	2.66	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1558.95	3.59	6.41	4.62	6.67	2.57	1.28	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	1502.70	6.14	8.18	6.39	12.27	5.37	2.30	1.28	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	2461.73	2.27	6.82	7.57	12.12	5.30	3.03	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	1824.79	4.70	5.04	3.70	6.39	1.68	1.34	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1257.76	6.76	5.80	2.90	3.62	2.17	0.97	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1302.66	4.90	7.13	1.34	4.01	2.67	1.34	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1519.04	4.88	5.85	7.80	4.88	2.44	1.46	1.95	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1077.91	3.97	7.03	4.58	8.86	2.44	1.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1649.39	35.79	0.00	58.56	0.00	13.01	3.25	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1119.25	3.31	10.59	10.92	5.30	4.63	1.99	0.66	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1735.48	7.11	8.21	4.38	10.95	3.28	1.64	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1417.14	1.45	6.51	5.43	7.60	3.98	1.09	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1391.10	3.56	6.76	6.05	7.83	4.98	1.07	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1676.70	7.16	7.16	7.16	11.93	2.39	3.58	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1274.22	2.44	7.18	3.52	6.36	2.98	0.81	0.68	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	1203.66	2.42	2.42	2.42	2.96	0.54	0.81	0.27	0.00
immature langerhans cells, donor1	11904-125F5	1038.08	3.15	2.18	1.45	0.97	0.48	0.00	0.48	0.24
immature langerhans cells, donor2	11905-125F6	926.00	3.17	0.79	2.38	1.58	0.00	1.58	3.17	0.00
insula, adult, pool1	10039-101F3	1157.93	1.61	11.55	1.23	0.28	1.14	0.66	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	964.71	0.65	0.98	2.60	1.63	0.98	0.33	0.65	0.00
kidney, adult, pool1	10017-101C8	897.54	2.20	1.40	1.10	3.70	1.20	0.80	0.50	0.10
kidney, fetal, pool1	10045-101F9	741.31	0.78	1.13	0.50	0.78	0.57	0.50	0.21	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	1142.42	1.28	1.85	1.28	1.56	0.85	0.57	0.57	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	990.64	3.18	2.49	2.90	2.49	0.97	1.66	0.69	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	651.97	0.55	1.10	0.73	1.28	0.00	0.18	0.00	0.00
left atrium, adult, donor1	10079-102A7	1179.06	4.36	2.72	2.72	1.63	2.18	2.72	1.09	0.54
left ventricle, adult, donor1	10078-102A6	939.00	2.02	2.53	2.02	0.00	2.02	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	824.66	0.27	2.74	1.64	1.37	0.55	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	3755.95	23.71	16.17	21.20	12.57	13.29	5.75	4.31	6.47
leiomyoma cell line:15242A	10570-108B3	3005.45	20.65	11.41	17.93	5.43	16.85	2.17	2.72	3.26
leiomyoma cell line:15425	10571-108B4	2825.89	19.43	11.90	12.63	5.58	10.93	4.61	3.64	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	774.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	712.02	0.00	0.00	2.09	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1031.00	3.42	0.71	0.83	0.83	0.83	0.12	0.24	0.24
liposarcoma cell line:KMLS-1	10782-110G8	1592.72	2.34	2.50	2.50	2.50	2.19	1.41	0.78	0.16
liposarcoma cell line:SW 872	10726-110A6	3114.09	5.12	5.24	3.78	4.14	3.17	1.83	0.97	0.24
liver, adult, pool1	10018-101C9	43.76	0.16	0.32	0.00	0.16	0.00	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	106.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	1264.44	0.15	1.17	1.17	1.31	0.29	0.87	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	792.83	1.66	1.11	0.74	0.55	0.55	1.11	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	1172.85	2.26	6.49	6.49	1.13	2.54	3.39	1.97	0.00
locus coeruleus, newborn, donor10223	10362-105F2	879.09	0.84	0.84	2.52	1.26	0.84	0.42	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	1130.13	1.80	1.52	1.25	1.52	0.83	0.69	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	813.50	0.69	0.69	0.69	4.83	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	1040.82	0.79	5.80	3.03	3.56	1.32	1.32	0.13	0.40
lung, adult, pool1	10019-101D1	353.08	0.71	1.18	0.95	2.60	0.71	0.35	0.12	0.00
lung, fetal, donor1	10068-101I5	442.10	0.00	0.29	1.14	0.29	0.57	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	394.98	0.92	2.75	0.92	1.83	0.00	1.37	0.00	0.46
lymph node, adult, donor1	10077-102A5	418.93	1.89	0.95	1.89	1.42	0.47	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	1732.60	1.53	2.63	1.32	3.73	3.29	1.53	0.88	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	3102.60	11.02	4.98	5.58	3.32	3.17	2.57	1.21	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	891.12	0.00	0.85	0.85	1.70	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	89.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	112.07	0.42	0.42	0.00	0.42	0.00	0.00	0.21	0.00
mature adipocyte, donor3	12233-129G1	161.68	0.24	0.24	0.00	0.00	0.24	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	94.76	0.26	0.53	0.26	0.26	0.00	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	583.97	1.19	0.48	0.00	1.19	0.48	1.19	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	1346.87	2.26	3.38	0.00	0.00	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	1012.22	1.10	1.84	0.92	0.37	0.92	0.37	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	1451.83	3.18	2.54	1.27	0.95	1.59	0.95	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	356.97	2.56	3.41	1.28	0.00	0.85	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	1124.56	2.70	6.92	1.52	0.17	1.86	1.35	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	959.68	1.49	0.85	0.64	0.21	0.64	1.06	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	2242.17	0.00	1.93	3.85	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1966.45	14.35	14.35	14.35	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	651.10	1.79	3.59	0.36	0.00	0.36	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	1383.62	1.30	0.65	0.65	7.14	0.00	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	892.13	2.01	0.62	0.93	1.39	0.77	0.15	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	906.31	1.14	0.82	0.57	0.24	1.06	0.08	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	1153.68	0.35	2.08	1.04	0.35	0.69	1.39	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1185.44	3.10	1.99	2.21	1.77	1.55	0.22	0.66	1.33
medulloblastoma cell line:ONS-76	10759-110E3	1418.12	1.10	1.71	2.20	1.96	0.73	0.49	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	1311.54	2.30	2.59	2.87	3.45	1.72	0.43	0.29	0.14
melanoma cell line:G-361	10465-106H6	937.63	1.90	6.24	2.17	12.22	1.36	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	1259.82	11.94	4.52	6.87	2.53	4.52	1.81	1.81	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	1112.02	4.41	2.64	7.05	2.64	2.64	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	976.23	5.96	1.81	3.37	0.78	1.56	1.04	0.78	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	2017.20	9.05	2.45	5.83	3.22	3.53	1.53	0.61	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	1305.00	5.27	1.27	3.09	1.45	2.91	0.55	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	3114.88	8.28	4.97	8.28	2.90	2.90	0.41	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2318.54	7.87	2.67	4.78	1.83	2.53	1.69	1.12	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1901.03	9.05	3.27	4.24	2.89	2.31	1.16	0.96	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	2514.64	17.35	9.02	5.55	4.16	4.86	4.16	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	985.35	3.26	1.89	2.23	2.75	2.23	1.20	0.17	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	1892.12	8.51	4.49	4.95	2.76	2.65	2.19	1.50	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	1736.88	6.50	2.39	5.04	1.06	2.79	0.66	0.27	1.72
mesenchymal precursor cell - cardiac, donor4	11755-123G9	1638.85	5.81	3.51	4.05	1.89	3.78	1.49	0.81	1.89
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	2134.51	8.39	2.42	4.41	3.13	2.99	1.99	0.71	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1258.14	4.94	0.66	0.66	3.62	2.31	0.99	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	2166.76	6.23	3.04	4.84	1.66	3.04	2.77	0.55	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	3460.81	15.36	7.68	3.84	7.33	5.24	0.35	2.44	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1946.71	8.57	2.65	5.10	2.86	2.86	0.61	0.82	1.63
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	1844.36	8.63	4.31	2.16	5.75	1.80	1.08	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1878.23	6.52	1.76	3.93	1.55	1.97	1.34	0.62	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2846.25	14.36	7.98	5.24	6.61	3.65	2.74	2.28	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	2998.58	11.33	4.62	7.13	3.36	2.10	1.26	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1931.78	8.82	3.44	5.83	3.29	2.24	1.34	1.05	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	2309.32	10.24	3.59	4.99	2.28	3.24	1.75	1.14	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	1866.57	5.52	4.79	4.42	1.47	2.58	1.84	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	2197.12	14.31	8.01	4.29	4.29	3.43	2.00	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	4261.09	35.37	8.42	16.00	8.00	14.31	6.32	4.63	5.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	1493.31	6.39	1.83	5.48	4.11	2.28	1.83	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	1432.14	3.84	4.60	3.58	2.81	1.79	1.28	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	1466.10	4.19	2.09	4.71	3.66	2.36	0.79	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	1451.70	4.01	3.39	4.62	2.77	4.93	0.92	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	1412.60	9.18	2.59	4.47	2.59	2.35	2.12	0.94	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	1577.21	6.77	2.03	4.40	1.69	1.69	2.03	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	1589.18	4.32	2.75	3.14	1.57	0.39	1.96	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	1525.47	9.73	4.17	3.71	2.78	2.32	0.46	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	2366.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	1785.59	10.09	5.19	4.04	6.92	4.33	1.44	1.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	1558.13	4.69	3.57	2.90	4.24	2.23	0.67	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	1681.50	4.09	4.33	2.40	2.40	3.36	1.92	1.44	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	1137.39	2.20	4.40	5.13	4.40	0.00	0.73	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	1603.10	6.71	4.03	4.03	3.02	2.35	1.01	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	1686.23	9.01	2.05	2.05	4.50	0.82	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	1695.47	5.15	2.15	3.01	3.01	1.72	3.01	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2108.23	5.47	0.00	5.47	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	1828.41	25.82	5.16	5.16	10.33	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	1684.02	9.74	3.25	4.87	1.30	3.57	0.65	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1757.63	5.82	0.00	4.36	0.00	2.91	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1921.22	9.06	2.67	4.26	1.07	4.80	1.60	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	1397.57	8.18	1.64	3.27	0.82	4.91	1.64	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	1611.25	6.61	3.50	5.05	1.17	3.50	1.94	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	1599.23	10.49	0.00	4.20	4.20	6.30	4.20	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1746.52	10.93	2.98	4.97	1.99	3.97	0.00	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	1735.27	28.60	4.77	4.77	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1727.31	8.30	3.56	3.56	2.96	4.15	0.59	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1629.08	9.75	2.44	4.87	0.00	1.22	2.44	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	1596.10	0.00	0.00	27.05	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	1672.76	6.33	3.17	5.07	3.17	1.27	1.27	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	1127.15	3.10	0.69	3.45	1.38	2.76	0.34	0.34	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	1096.09	6.45	4.30	6.45	2.15	0.00	2.15	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	1029.88	0.00	7.98	0.00	3.99	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	447.70	10.33	6.89	3.44	0.00	0.00	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	388.32	2.04	0.81	0.81	0.81	0.81	0.41	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	428.20	1.59	0.79	0.00	0.79	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	269.41	2.36	0.59	0.59	0.00	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	263.70	0.94	0.00	0.31	0.31	0.94	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	257.98	4.01	1.34	0.00	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	334.70	2.37	3.55	1.18	4.73	1.18	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	333.84	7.70	0.00	0.00	2.57	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	351.08	1.38	0.69	1.38	0.69	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	271.65	1.48	0.99	0.00	1.98	0.99	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	226.54	3.36	0.00	0.00	0.00	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	241.70	1.27	0.00	0.64	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	384.45	2.01	0.40	1.21	0.00	0.81	0.40	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	431.76	10.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	394.06	2.53	1.27	1.27	2.53	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	198.45	1.21	0.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	234.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	201.80	0.82	1.65	0.82	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	383.76	0.20	0.99	0.79	0.60	0.40	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	475.71	1.30	0.32	0.32	0.65	0.97	1.30	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	444.12	2.04	1.02	2.04	2.04	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	454.94	0.00	0.00	0.77	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1059.07	0.47	1.89	1.42	2.60	0.24	1.18	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	695.02	0.93	1.39	1.85	0.93	0.93	0.46	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	2453.04	8.55	0.00	0.00	12.82	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1828.54	17.98	3.29	3.80	1.34	3.90	1.23	1.13	0.92
mesothelioma cell line:Mero-25	10850-111F4	1017.66	3.63	1.36	2.50	1.59	2.72	0.45	0.45	0.68
mesothelioma cell line:Mero-41	10851-111F5	2840.07	9.78	4.40	6.11	4.65	3.42	3.42	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	2478.92	9.74	4.65	5.31	2.66	3.32	1.77	1.11	0.89
mesothelioma cell line:Mero-82	10853-111F7	1658.56	7.36	3.94	5.52	4.99	3.94	3.42	0.79	2.10
mesothelioma cell line:Mero-83	10854-111F8	3102.61	13.62	5.62	4.77	6.98	3.92	1.53	1.36	1.02
mesothelioma cell line:Mero-84	10855-111F9	2269.66	8.09	4.04	3.03	1.77	2.78	1.77	1.01	1.01
mesothelioma cell line:Mero-95	10856-111G1	2729.86	10.15	6.83	5.18	6.63	3.73	3.11	0.83	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	1827.43	6.46	3.48	1.82	2.82	0.33	0.83	0.66	0.50
mesothelioma cell line:NCI-H226	10846-111E9	3609.88	13.39	8.69	6.70	4.71	2.90	2.53	1.45	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	2905.34	9.91	6.32	4.44	4.61	3.25	2.39	0.85	1.20
mesothelioma cell line:NCI-H28	10845-111E8	4975.83	22.90	11.96	12.47	12.21	5.34	5.60	2.54	2.29
mesothelioma cell line:No36	10857-111G2	1394.19	4.57	2.94	2.61	1.30	2.61	0.33	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	2200.40	5.96	4.06	5.15	2.98	3.25	3.79	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	3239.08	8.64	5.76	5.18	1.92	3.65	2.30	0.77	0.77
migratory langerhans cells, donor2	11902-125F3	2863.61	7.69	3.42	5.37	2.20	1.95	1.47	0.49	0.61
migratory langerhans cells, donor3	11903-125F4	1908.60	7.00	1.44	1.79	2.15	1.44	1.97	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	1080.32	9.47	10.45	7.51	6.20	4.90	2.94	1.31	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	3385.47	18.65	8.90	9.96	5.93	9.75	3.81	3.81	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1093.51	0.46	1.38	1.61	2.53	0.46	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2620.70	4.57	4.00	5.52	4.57	4.19	1.71	1.14	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	861.69	1.66	1.11	2.03	0.55	1.85	0.55	0.00	0.00
myeloma cell line:PCM6	10474-106I6	1259.34	1.78	2.77	1.58	2.37	0.99	0.79	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	2548.12	0.00	2.54	3.55	3.04	2.54	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1552.25	3.92	2.16	1.96	4.51	1.18	0.98	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	402.80	0.89	0.33	0.89	0.22	0.00	0.45	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	409.55	0.59	1.03	0.66	0.29	0.29	0.22	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	792.66	0.55	1.66	2.76	1.10	0.55	1.10	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	507.74	0.46	0.46	0.23	0.69	0.23	0.23	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	1074.99	1.31	0.94	1.87	0.75	1.31	0.19	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	400.69	1.27	0.21	0.21	1.69	0.00	0.21	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	706.83	2.61	0.37	1.30	0.56	0.19	0.00	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	373.16	1.66	0.71	0.71	0.24	1.19	0.47	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1445.86	6.97	4.28	3.96	3.48	3.01	1.11	0.79	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	647.65	1.81	0.40	1.81	1.21	0.40	1.21	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	498.44	0.64	0.64	0.00	1.91	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	1986.93	2.66	2.13	2.93	3.73	2.66	0.80	0.27	0.00
neutrophil PMN, donor1	12133-128D9	594.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	863.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	1240.65	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1731.29	3.38	2.88	2.54	2.20	1.01	1.01	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	726.06	2.40	1.60	4.00	0.00	0.00	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	868.20	3.21	3.85	2.56	2.24	3.85	0.96	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	1594.98	7.62	3.68	2.10	4.99	4.47	1.31	2.36	0.53
nucleus accumbens, adult, pool1	10037-101F1	1052.97	0.75	4.59	1.31	0.19	1.12	0.37	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	1345.43	2.06	2.06	0.00	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	875.13	2.68	0.54	0.81	1.61	0.54	0.81	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	789.76	1.82	4.37	0.00	0.36	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	1128.32	5.51	4.20	3.41	1.05	2.10	0.52	1.31	0.79
occipital lobe, fetal, donor1	10073-102A1	435.11	1.72	1.29	0.43	1.29	0.43	1.29	0.43	0.86
occipital pole, adult, pool1	10036-101E9	1136.18	1.10	4.57	0.79	0.47	0.79	0.32	0.08	0.24
olfactory region, adult	10195-103E6	946.47	2.48	2.48	0.96	0.57	1.53	0.38	0.19	0.00
optic nerve, donor1	10277-104E7	342.18	0.00	0.00	2.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	1363.71	3.19	3.42	1.25	2.62	1.03	0.68	0.23	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1514.41	1.79	1.10	0.82	1.79	0.82	0.69	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	1118.89	7.45	2.20	1.86	2.20	2.20	1.02	0.51	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	569.69	2.08	0.92	1.39	1.04	0.58	0.46	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	1728.53	2.65	6.76	3.53	3.82	1.76	1.47	0.88	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	613.86	0.00	0.00	0.00	1.87	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	818.34	1.27	1.27	1.27	2.12	0.85	1.06	0.00	0.21
ovary, adult, pool1	10020-101D2	288.70	0.09	0.79	0.61	1.14	0.52	0.17	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	2232.84	5.32	5.68	5.68	6.78	4.95	2.20	0.37	0.18
pancreas, adult, donor1	10049-101G4	172.14	1.88	0.94	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	623.92	1.40	0.84	1.40	1.12	1.12	0.56	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	1157.04	10.22	4.94	3.92	1.87	2.56	1.19	1.53	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	805.56	1.16	2.32	0.99	1.82	0.66	0.17	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	1145.40	1.56	4.39	1.19	0.09	0.27	0.64	0.09	0.18
parietal cortex, adult, donor10258	10373-105G4	1194.96	0.73	2.20	0.73	0.73	0.73	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	1133.28	1.88	0.94	0.94	0.00	0.00	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	1155.25	3.14	1.43	0.86	1.43	1.14	0.57	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	1074.09	0.97	3.52	0.70	0.00	0.53	0.88	0.35	0.09
parietal lobe, fetal, donor1	10072-101I9	453.88	1.94	0.97	1.94	0.00	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	706.97	0.37	2.99	0.00	0.75	0.75	0.37	0.00	0.00
parotid gland, adult	10199-103F1	347.80	1.23	0.62	0.00	0.62	0.62	0.00	1.23	1.23
penis, adult	10200-103F2	998.49	3.22	8.59	3.76	1.07	3.76	2.69	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	769.03	3.16	1.30	1.67	1.30	1.67	0.37	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1639.50	3.79	3.06	6.26	3.21	2.48	1.75	0.87	0.29
pineal gland - adult, donor10196	10179-103C8	2008.62	1.29	1.29	1.29	0.00	1.29	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	1049.99	0.59	1.78	3.55	0.00	1.78	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	1325.01	1.88	1.88	1.25	1.25	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	501.85	2.02	1.01	0.00	1.01	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	452.91	0.00	0.00	1.56	1.56	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	426.47	1.70	0.00	0.00	0.00	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	368.52	0.75	1.08	0.32	0.97	0.00	0.11	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	1082.59	2.78	2.52	3.58	1.99	0.13	1.72	0.66	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1082.32	3.27	2.33	2.33	1.40	1.71	0.78	0.31	0.16
pons, adult, pool1	10033-101E6	1270.70	0.95	0.95	0.95	0.60	1.03	0.69	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	1110.44	1.83	3.92	1.31	0.09	1.39	1.05	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	466.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	1074.07	5.51	5.51	5.51	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	833.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	2621.33	9.61	3.93	4.37	2.48	3.35	2.33	1.17	0.87
prostate cancer cell line:PC-3	10439-106E7	1606.65	3.99	3.27	1.82	2.90	1.09	0.36	0.36	0.18
prostate, adult, pool1	10022-101D4	339.28	0.27	0.73	0.27	1.45	0.82	0.18	0.09	0.09
putamen, adult, donor10196	10176-103C5	1165.21	2.60	3.07	0.71	0.24	0.71	0.47	0.47	0.47
putamen, adult, donor10252	10152-102I8	439.20	0.00	0.00	1.96	3.92	1.96	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	1580.20	0.00	0.00	0.00	0.00	1.09	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	993.75	1.45	0.97	0.97	0.72	0.48	0.72	0.24	0.24
putamen, newborn, donor10223	10365-105F5	1134.24	0.00	1.50	2.25	0.00	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	293.55	1.16	0.58	0.87	0.87	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	507.71	0.00	0.00	1.39	1.39	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	2349.79	8.27	4.24	2.76	2.97	3.60	2.76	1.48	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	827.59	2.90	2.07	1.24	1.66	1.24	1.66	0.00	0.41
retina, adult, pool1	10030-101E3	1003.34	1.39	0.60	0.80	0.60	0.70	0.70	0.40	0.00
retinoblastoma cell line:Y79	10475-106I7	2747.15	8.57	2.60	3.38	1.04	2.34	2.60	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1158.79	1.97	1.23	3.44	0.98	0.98	0.74	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	418.43	0.28	0.56	0.56	1.97	0.28	0.28	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	624.47	0.00	1.52	1.52	3.79	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	1180.10	3.72	2.59	2.10	1.94	0.81	1.29	0.32	0.97
salivary acinar cells, donor2	11772-123I8	1139.09	4.82	4.68	3.44	5.09	1.79	1.51	1.38	0.96
salivary acinar cells, donor3	11773-123I9	501.17	0.00	0.00	0.00	2.65	0.66	2.65	0.00	0.00
salivary gland, adult, pool1	10093-102C3	653.74	0.00	1.72	0.00	1.14	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1753.34	2.61	2.11	2.28	2.87	2.11	0.51	0.25	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1471.87	2.23	2.23	2.00	2.94	1.65	0.71	0.24	0.12
seminal vesicle, adult	10201-103F3	469.29	2.65	4.76	3.70	2.65	0.53	3.70	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	672.17	4.37	1.94	3.16	1.46	0.97	0.24	0.97	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	3143.89	17.36	6.54	5.03	6.29	2.77	2.77	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4879.18	18.06	9.03	7.02	8.03	4.01	3.01	2.01	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	626.07	2.28	0.27	0.54	0.94	0.81	0.13	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	1255.26	2.21	1.11	1.33	2.32	0.66	0.44	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	647.96	0.39	0.77	0.52	0.90	0.77	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	1402.36	7.09	1.42	1.42	0.00	2.13	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	840.40	1.08	1.20	1.32	0.48	1.08	0.96	0.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	1158.78	5.03	2.01	5.03	2.01	3.02	2.01	2.01	0.00
skin, adult, donor1	10074-102A2	447.82	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	387.57	4.42	0.63	0.00	0.00	0.00	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	890.84	1.33	1.33	3.67	2.00	2.00	1.33	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1056.88	5.67	1.58	1.89	1.89	2.21	0.95	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	371.23	1.73	1.35	1.73	0.96	0.19	0.96	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	1841.94	1.65	1.98	2.47	2.31	0.33	0.49	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2823.88	4.34	4.02	3.38	3.54	1.77	1.45	2.09	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	605.59	1.09	1.53	0.22	0.87	1.09	0.22	0.00	0.00
small intestine, adult, pool1	10024-101D6	422.23	1.55	1.31	1.07	2.99	0.84	0.48	0.12	0.00
small intestine, fetal, donor1	10064-101I1	264.37	1.97	0.98	0.25	0.98	0.25	0.25	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1497.16	11.80	3.59	5.64	3.59	5.64	2.56	2.56	1.54
smooth muscle, adult, pool1	10048-101G3	297.74	0.52	0.52	0.78	0.26	1.03	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	434.46	0.54	0.27	0.54	0.80	0.00	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	719.88	1.61	2.29	0.92	0.46	0.92	0.23	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	353.66	0.00	0.00	1.58	0.00	0.79	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	999.65	3.46	0.00	1.38	1.38	1.38	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	662.28	4.88	1.83	0.00	1.22	0.61	2.44	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	620.86	3.21	1.84	2.30	0.92	0.46	0.00	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	1593.76	1.94	3.58	2.39	3.44	1.05	0.90	0.30	0.15
spleen, adult, pool1	10025-101D7	430.07	0.77	0.77	0.88	1.87	0.55	0.55	0.22	0.11
spleen, fetal, pool1	10044-101F8	417.46	0.56	0.95	0.48	0.72	0.16	0.24	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1466.15	3.52	2.07	1.97	0.72	0.72	0.93	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	437.28	0.76	0.57	0.95	1.33	0.19	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	670.25	2.80	0.35	1.05	1.75	0.70	1.40	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	926.12	2.35	2.35	1.17	1.56	2.74	1.56	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1153.39	1.91	1.58	1.69	1.35	0.90	0.68	0.79	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1113.65	6.35	2.97	0.85	2.12	0.85	1.27	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	1673.67	1.69	2.54	0.85	2.12	0.00	1.27	0.00	0.42
stomach, fetal, donor1	10062-101H8	413.31	1.07	1.07	1.07	1.07	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	472.27	5.13	1.71	0.57	2.85	1.71	1.14	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	1085.48	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	407.31	2.08	0.62	0.62	0.83	0.00	0.62	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	1654.17	1.03	2.07	1.55	1.03	0.52	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	927.73	0.71	0.00	0.71	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	753.37	2.98	1.83	1.15	0.46	1.15	0.69	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	1057.68	2.29	8.22	1.44	0.08	1.10	0.59	0.34	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	341.89	1.42	2.85	0.00	0.00	0.00	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	430.31	3.52	1.76	0.88	0.00	0.00	0.44	0.00	0.44
tenocyte, donor1	11763-123H8	1833.48	13.96	8.73	3.14	4.19	3.14	3.14	0.70	0.70
tenocyte, donor2	11765-123I1	1055.24	3.82	1.53	0.38	0.76	1.14	1.14	0.76	1.14
tenocyte, donor3	11768-123I4	1557.54	11.86	5.56	2.97	3.71	2.97	1.85	2.22	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	2082.53	5.61	4.08	5.78	2.72	2.72	1.53	1.02	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	3893.63	11.87	9.71	9.40	10.94	5.55	4.32	2.77	0.92
teratocarcinoma cell line:PA-1	10807-111A6	1601.85	2.63	3.25	2.32	3.72	1.39	1.08	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1094.03	2.67	3.43	2.67	4.32	1.40	0.76	0.76	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	683.74	1.13	0.38	1.13	1.13	0.00	0.76	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	418.47	1.74	0.44	0.65	0.98	0.33	0.44	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1267.31	10.10	5.86	4.89	3.91	2.93	2.61	1.30	0.33
testis, adult, pool1	10026-101D8	394.16	0.97	1.83	1.50	1.72	1.40	0.43	0.21	0.00
testis, adult, pool2	10096-102C6	661.29	5.41	2.71	2.71	1.80	1.80	0.90	0.45	0.00
thalamus - adult, donor10196	10168-103B6	1130.48	2.21	0.00	0.00	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	572.46	2.19	1.25	0.16	1.25	0.47	0.16	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	3730.49	0.00	0.00	4.62	1.54	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	1799.07	2.31	4.28	2.31	0.33	1.65	1.65	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	1303.10	2.30	0.58	1.15	0.00	0.58	1.73	0.00	0.00
throat, adult	10209-103G2	890.07	7.74	1.75	1.50	0.75	1.00	1.00	1.00	0.75
throat, fetal, donor1	10061-101H7	475.04	2.13	0.61	0.30	0.91	0.91	0.00	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	966.23	2.38	0.79	0.99	0.60	0.99	0.40	0.79	0.00
thymus, adult, pool1	10027-101D9	371.81	1.39	0.80	0.60	2.09	0.89	0.10	0.10	0.00
thymus, fetal, pool1	10043-101F7	510.17	1.04	1.04	0.42	1.56	0.21	0.21	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	2739.79	4.52	4.52	3.59	2.79	1.86	1.06	0.93	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	1355.28	3.07	3.07	1.96	1.96	1.96	0.56	0.84	0.00
thyroid, adult, pool1	10028-101E1	335.93	0.47	0.84	0.47	0.65	0.09	0.28	0.09	0.00
thyroid, fetal, donor1	10060-101H6	397.60	1.05	1.32	1.58	0.26	0.53	0.26	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	967.00	0.00	9.24	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	1432.68	10.00	4.42	2.79	2.33	2.56	1.86	0.93	1.86
tongue, fetal, donor1	10059-101H5	1501.10	4.34	3.55	1.58	0.39	1.18	1.18	0.39	0.39
tonsil, adult, pool1	10047-101G2	777.76	0.60	1.10	0.70	1.30	0.60	0.20	0.20	0.20
trachea, adult, pool1	10029-101E2	781.75	1.39	1.88	0.49	2.86	0.65	0.41	0.00	0.08
trachea, fetal, donor1	10058-101H4	726.30	3.08	0.38	0.77	1.15	1.15	0.77	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	2191.90	7.79	4.96	5.31	5.67	3.90	1.06	0.71	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	1232.21	1.52	0.61	1.01	1.72	0.20	0.30	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	787.20	1.72	2.35	1.72	2.66	1.10	0.63	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	1738.91	0.00	1.90	0.00	7.61	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1694.02	3.56	2.29	2.03	3.05	0.76	0.68	0.68	0.17
umbilical cord, fetal, donor1	10057-101H3	532.06	6.26	0.00	0.00	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	297.75	0.00	0.17	0.34	0.17	0.00	0.51	0.00	0.00
uterus, fetal, donor1	10055-101H1	1045.87	4.61	1.02	2.05	0.51	2.56	0.51	0.51	0.51
vagina, adult	10204-103F6	376.09	0.00	0.65	0.65	0.00	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	342.39	1.75	2.19	1.32	1.53	1.53	0.00	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1508.76	4.01	1.87	4.81	2.14	2.94	0.80	0.00	0.00